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1 
Introduction 
___________________________________ 
 
1.1 The  skin 
 
The skin represents the body´s largest organ system and is the principle site of 
interaction with the environment. The skin serves as a barrier which mediates 
protection against harmful environmental conditions, such as mechanical damage, 
noxious agents, invading pathogens and ultraviolet light. Moreover, the skin limits 
water loss and participates in the maintenance of body temperature. Special 
receptors enable the skin organ system to sense heat, cold, pain and pressure 
(Thews et al., 1999; Freinkel and Woodley, 2001). 
The skin consists of the outer epidermal, the underlying dermal and the 
subcutaneous layers. Comparable to other epidermal structures in the body, the 
epidermis represents a stratified, self-renewing tissue compartment of multiple cell 
types. Keratinocytes represent the major epidermal cell type and are responsible for 
cutaneous barrier function. To a lesser extent, melanocytes (melanin synthesis), 
Langerhans cells (antigen-presenting), and Merkel cells (sensory functions) are 
found in the epidermal layer. Keratinocytes are organized into four different layers 
that correspond to the progressive stages of differentiation: stratum basale, stratum 
spinosum, stratum granulosum, and stratum corneum. While passaging through 
these layers, keratinocytes show an increase in size and cell flattening, they loose 
organelles, change their keratin (intermediate filament protein) expression and are no 
longer able to proliferate (Haake et al., 2001). The stratum basale is separated by a 
basement membrane from the underlying dermis. It consists primarily of mitotically 
active keratinocytes, namely keratinocyte stem cells, and transient amplifying cells 
(Bickenbach, 1981; Lavker and Sun, 1982; Bickenbach and Mackenzie, 1984). The 
stem cells are self-renewing and able to produce daughter transient amplifying
 (TA) 
cells that undergo a finite number of cell divisions before
 they differentiate and leave 
the proliferative basal compartment (Lajtha, 1979; Potten, 1997). The stratum 
spinosum is characterized by polyhedral keratinocytes, connected by desmosomes 
(intercellular adhesion complexes). The keratinocytes of the granular layer (stratum  Introduction 
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granulosum) contain keratinohyaline granules (Holbrooke, 1989). Within these 
granules the filaggrin precursor is present which promotes aggregation of keratin 
filaments (Fukuyama et al., 1980; Dale, 1990). In the stratum corneum itself, the 
keratinization process ends with terminally differentiated cells, the corneocytes. 
Corneocytes are lacking nuclei and cytoplasmic organelles and form a resistant 
keratinous skeleton. 
The dermis is the connective tissue component of the skin. The structural 
components of the dermis include collagen and elastic fibres as well as 
glycoproteins, proteoglycans and glycosaminoglycans (Uitto et al., 1999; Sakai et al., 
1986; Yanagishita, 1994). Epidermal appendages, neurovascular networks, sensory 
receptors and dermal cells are embedded within. The dermis can be divided into the 
upper papillary dermis and the lower reticular dermis. The papillary dermis supplies 
the epidermis with nutrients and oxygen. It is characterized by a high cellularity, since 
fibroblasts and resident immune cells (lymphocytes, monocytes, macrophages, and 
mast cells) are located here. The lower reticular dermis is rich in collagen and elastic 
fibers and thereby provides elasticity and tensile strength. The innermost 
subcutaneous layer is predominantly consisting of adipocytes which are organized 
into lobules defined by septa of fibrous connective tissue. Nerves, vessels and 
lymphatics are located within the septa and richly supply the region. The hypodermis 
has the ability to protect the body from cold, to absorb trauma, and finally, it serves 
as an additional energy storage. Actively growing hair follicles extend into the 
subcutaneous fat and the apocrine and eccrine sweat glands are normally confined 
to this depth of the skin (Haake et al., 2001).  
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Figure 1 Overview of human skin architecture 
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1.2.  Phases of cutaneous wound repair 
 
The wound healing process which is initiated immediately upon injury is subdivided 
into different temporally and spatially overlapping phases, namely hemorrhage, 
inflammation, reepithelialization, granulation tissue formation and, the late phase of 
repair (Singer and Clark, 1999).  
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Figure 2 Phases of cutaneous wound repair. 
Healing of a wound comprises different phases: (A) inflammation (early and late), (B) 
reepithelialization, angiogenesis and granulation tissue formation, and (C) matrix formation and 
remodeling. These wound repair processes are plottet along the abscissa as a logarithmic function of 
time. The phases of wound repair overlap in a temporal manner. Inflammation is divided into early and 
late phases denoting neutrophil-rich and monocytic-rich infiltrates, respectively. Begin of wound 
contraction is indicated by an arrow. Collagen accumulation begins shortly after the onset of 
granulation tissue formation (Clark, 1996: modified) 
 
 
1.2.1.  Hemorrhage 
 
Wounding disrupts blood vessels and causes hemorrhage. Platelet aggregation and 
blood coagulation occurs, and a fibrin clot is formed. The clot is mainly composed of 
cross-linked fibers derived by thrombin-mediated cleavage of fibrinogen. Small 
amounts of plasma fibronectin, vitronectin and thrombospondin are also found (Clark, 
1996; Martin, 1997). Activated platelets release a variety of different factors: 
fibrinogen, fibronectin and thrombospondin act as ligands for platelet aggregation 
(Clark, 1996), while von Willebrand factor enables platelet adhesion to fibrillar  Introduction 
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collagens (Ruggeri, 1993). Furthermore, the fibrin clot serves as a matrix scaffold for 
the recruitment of circulating inflammatory cells to the wound site. The recruitment is 
ensured by different chemotactic and/or mitogenic factors released from 
degranulating platelets. These factors include the platelet-derived growth factor 
(PDGF), epidermal growth factor (EGF), transforming growth factor-α  and -β  (TGF-α , 
TGF-β ) and insulin-like growth factor-1 (IGF-1) (Ross and Raines, 1990; Derynck, 
1988; Sporn and Roberts, 1992; Naney and King, 1996; Rappolee et al., 1988). 
Taken together, the blood clot reestablishes hemostasis, it represents a matrix for 
invading cells and it serves as a reservoir of growth factors, required during the later 
stages of tissue regeneration. 
 
 
1.2.2   Inflammation 
 
The inflammatory phase starts as polymorphonuclear neutrophils (PMN) enter the 
wound bed. PMN, which are potently attracted by the CXC- (α -) chemokines 
including interleukin-8 (IL-8) (Luster, 1998; Baggiolini, 1998), arrive in great numbers 
within minutes after wounding. Additionally, PMN are attracted by more general 
leukocyte chemoattractants, such as fibrinopeptides (cleaved from fibrinogen by 
thrombin), fibrin degradation products (produced by plasmin degradation of fibrin), 
C5a (generated after the activation of the complement cascade), leukotriene B4 
(released by activated neutrophils), platelet activating factor (PAF, released from 
endothelial cells or activated neutrophils) ( Clark, 1996). They immediately start to 
attack bacteria in the wound area via phagocytosis, enzymatic mechanisms and 
production of highly reactive oxygen species (ROS) (Tonnesen et al., 1988; Elsbach 
and Weiss, 1992; Klebanoff, 1992). Notably, PMN have been shown to produce IL-
1α , -1β  and TNF-α  which are early activators of growth factor expression in 
macrophages, keratinocytes, and fibroblasts (Hübner et al., 1996). Recently, Dovi et 
al. (2003) investigated the role of neutrophils in wound healing by neutrophil 
depletion. Neutropenia, induced by injection of a rabbit anti-mouse neutrophil serum, 
accelerated the rate of wound epithelial closure without altering the overall quality of 
the dermal healing process. During undisturbed healing, neutrophil cell number 
rapidly declines after a few days. Neutrophils become entrapped within the wound 
clot or die by apoptosis. The cells are subsequently phagocytosed by macrophages 
(Newman et al., 1982). While neutrophil cell numbers decline, macrophages (Mφ )  Introduction 
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continue to accumulate, thus becoming the predominant leukocyte cell type. 
Monocytes are preferentially attracted through CC- (β -) chemokines such as 
macrophage inflammatory protein-1α  (MIP-1α ) and monocyte chemoattractant 
protein-1 (MCP-1) (DiPietro et al., 1995, 1998). Factors that trigger the process of Mφ  
activation are tissue debris, bacterial factors, cell-derived mediators and 
microenvironmental conditions (e.g. hypoxia). Activated Mφ  release a variety of 
growth factors and cytokines (DiPietro et al., 1995; Moulin, 1995), mediating 
angiogenic (basic fibroblast growth factor [bFGF], TGF-α , TGF-β , TNF-α ) or fibrotic 
(PDGF,TGF-β ) properties. Mφ  facilitate extracellular matrix degradation by 
expression of matrix degrading proteases and by regulation of fibroblast 
metalloprotease secretion (Riches, 1996). Leibovich and Ross (1975) demonstrated 
the central role of the tissue Mφ  for wound repair, since depletion of Mφ  led to a 
severe impairment of wound healing. The authors observed a severe retardation of 
tissue debris and a delay in fibroblast proliferation and fibrosis. 
Close to the end of the inflammatory phase, T-lymphocytes come into play, peaking 
at day 7 of repair (Fishel et al., 1987). Their major function is assumed to be the 
downregulation of fibrous tissue growth. T-helper cells (CD4
+) drive the process of 
tissue regeneration while cytotoxic T-cells (CD8
+) are more likely to interfere with the 
repair process (Barbul and Regan, 1990). γδ T-cells are found to stimulate 
keratinocyte proliferation by producing keratinocyte growth factor (KGF) (Boismenu 
and Havran, 1994). Furthermore, T-cells release angiogenic mediators such as 
heparin-binding EGF (HB-EGF) and bFGF (Blotnick et al., 1994). T-cells and Mφ  are 
detectable beyond the acute inflammatory phase of repair suggesting a function 
which is not restricted to the inflammatory response during tissue regeneration. 
 
 
1.2.3 Reepithelialization 
 
The process of reepithelialization starts within hours upon injury as keratinocytes of 
the cut edge begin to migrate. Notably, hair follicle remnants behave like normal cut 
epidermal wound edges and spread out from the follicle stump (Martin, 1997; 
Gambardella and Barrandon, 2003). Keratinocyte migration is characterized by 
several morphological changes. The basal keratinocytes lose polarity which is 
maintained as long as the cells remain in contact to the basement membrane 
(Odland and Ross, 1968). Cells become flat and elongated, and form peripheral  Introduction 
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cytoplasmic actin filaments (lamellipodia) (Gabbiani et al., 1978). Remarkably, those 
keratinocytes display a more basal-like phenotype as they do not differentiate. 
However, they differ from cells of the basal layer as they contain involucrin, a cellular 
marker for keratinocyte differentiation (Mansbridge and Knapp, 1987). In order to 
crawl through the wound bed, the migrating cells must be able to sense extracellular 
matrix proteins. This active contact guidance is achieved by the expression of 
integrins that recognize the extracellular matrix components fibronectin, vitronectin 
and collagen (Clark, 1990; Clark et al., 1996). Furthermore, migrating keratinocytes 
have to lyse the provisional matrix of the wound bed. To this end, keratinocytes 
upregulate a fibrinolytic machinery that consists of enzymes such as tissue-type 
plasminogen activator and urokinase-type plasminogen activator (Grondahl-Hansen 
et al., 1988; Romer et al., 1991, 1994), and different members of the matrix 
metalloprotease (MMP) family such as gelatinase B (MMP-9) (Salo et al., 1994), 
interstitial collagenase (MMP-1) (Pilcher et al., 1997), and stromelysin-2 (MMP-10) 
(Saarialho et al., 1994). To overcome the loss of cells during wounding, epithelial 
cells start to proliferate at the wound margin. Different growth factors and growth 
factor receptors are discussed to initiate this proliferation (Singer and Clark, 1999). 
Members of the EGF and FGF family are considered to be key players (Nanney et 
al., 1990; Werner et al., 1994; Nanney and King, 1996; Abraham and Klagsbrun, 
1996; Werner and Grose, 2003). The EGF family of mitogens comprises several 
members, including EGF, TGF-α , and HB-EGF which exert their function via binding 
to the EGF-receptor (EGF-R). Binding to the EGF-R initiates a cascade of signal 
transduction events that induce migration and proliferation of keratinocytes 
(Barrandon and Green; 1987; Chen et al., 1994; Danilenko et al., 1995; Cha et al., 
1996;). Furthermore, EGF and TGF-α  were reported to enhance reepithelialization 
when exogenously applied to burn wounds (Brown et al., 1986; Schultz et al., 1987). 
FGF7 (keratinocyte growth factor, KGF-1) is a specific and potent growth factor for 
epithelial cells, at least in the adult organism (Werner, 1998). It has been shown that 
FGF7 is upregulated in both, mouse and human wounds (Werner et al., 1992; 
Marchese et al., 1995). FGF7 acts in a paracrine manner, since FGF7 mRNA is 
predominantly detected in dermal fibroblasts adjacent to the wound and in fibroblasts 
of the granulation tissue, but its specific receptor FGFR2IIIb (splice variant of FGF 
receptor 2 (FGFR2) (Ornitz et al., 1996)) is expressed in keratinocytes of the normal 
and wounded epidermis as well as in hair follicles of murine, porcrine, and human  Introduction 
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wounds (Danilenko et al., 1995; Marchese et al., 1995). It has been demonstrated by 
Werner  et al. (1994) that wounds of transgenic mice which express a dominant-
negative FGFR2IIIb mutant in the epidermis displayed a severe delay in 
reepithelialization. Another factor that participates in the process of reepithelialization 
is nitric oxide (NO). NO has been convincingly shown to be a mitogenic mediator for 
keratinocytes in vitro (Krischel et al., 1998; Frank et al., 2000a) and in vivo (Frank et 
al., 2002; Stallmeyer et al., 1999; Yamasaki et al., 1998; Frank et al., 1998a). 
Additionally, the cytokine leptin contributes to cutaneous reepithelialization processes 
(Frank et al., 2000b; Stallmeyer et al., 2001). 
TGF-β 1 has been suggested as a negative regulator of keratinocyte proliferation in 
vitro and in vivo (Coffey et al., 1988; Sarret et al., 1992; Sellheyer et al., 1993).  
 
 
1.2.4   Granulation tissue formation 
 
Formation of the granulation tissue starts approximately 4 days after injury. Mφ , 
fibroblasts, and blood vessels move into the wound bed at the same time (Hunt, 
1980). Mφ  provide a continuous source of growth factors which stimulate fibrotic and 
angiogenic processes. Fibroblasts synthesize new extracellular matrix to support 
fibroblast and endothelial cell ingrowth. Newly formed blood vessels supply oxygen 
and nutrients to sustain cell metabolism. Fibroblasts located within the developing 
granulation tissue are characterized by three main capacities: proliferation, migration 
and production of extracellular matrix. Due to cytokines and extracellular-matrix 
molecules present at the wound site, resident fibroblasts adjacent to the injured 
tissue start to proliferate and move into the wounded area (Nathan and Sporn, 1991; 
Gray et al., 1993; Xu and Clark, 1996). Moreover, fibroblasts are activated to secrete 
important mediators such as KGF and connective tissue growth factor (CTGF) 
(Werner  et al., 1992; Igarashi et al., 1993). The actual migration of fibroblasts 
predominantly occurs via fibronectin bundles (Hsieh and Chen, 1983), which are the 
main component of the provisional blood clot. Binding to the substratum is mediated 
via integrin receptors on the surface of invading fibroblasts (Ruoslahti, 1991; Hynes, 
1992). The upregulation of integrins is induced by PDGF and TGF-β 1 (Heino et al., 
1989; Ahlen and Rubin, 1994; Gailit et al., 1996). In order to make their way through 
the provisional matrix fibroblasts also synthesize proteolytic enzymes, such as matrix 
metalloproteinases MMP-1 (collagenase), -2 (gelatinase) and -3 (stromelysin)  Introduction 
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(Mignatti, 1996; Vaalamo et al., 1997). After invading and activation, wound 
fibroblasts switch on extracellular matrix protein synthesis. The provisional 
extracellular matrix is gradually replaced by collagens (Welch et al., 1990). This 
collagen production is believed to be stimulated by TGF-β 1 (Ignotz and Massague, 
1986; Roberts et al., 1986) which is found in high amounts during the granulation 
phase of repair (Frank et al., 1996). Some fibroblasts differentiate into 
myofibroblasts, harboring smooth muscle actin and thus, provide the motive force for 
wound contraction (Desmouliere and Gabbiani, 1996). The contraction is likely to 
require stimulation by TGF-β 1, β 2 (Montesano and Orci, 1988) and PDGF (Clark et 
al., 1989), attachment of fibroblasts to the collagen matrix through integrin receptors 
(Schiro  et al., 1991), and cross-links between individual bundles of collagen 
(Woodley et al., 1991). Interestingly, wound contraction is only present in adult skin 
wounds, as fetal wounds heal without contraction (Ferguson et al., 1996; Martin, 
1996). The endpoint of granulation tissue formation is reached as fibroblasts undergo 
apoptosis and fibroblasts-rich granulation tissue is converted into a relative acellular 
scar (Desmouliere et al., 1995). 
 
 
1.2.5 Neovascularisation 
 
New blood vessels are formed in the granulation tissue in order to supply the newly 
formed tissue with oxygen and nutrients. Invading endothelial cells derive from the 
microvasculature (Madri et al., 1991, 1992a,b). Capillary buds sprout from blood 
vessels adjacent to the wound and extend into the wound space. On the sprouting tip 
of ingrowing capillaries α Vβ 3 integrins are present, allowing binding to fibrin, 
fibronectin and vitronectin of the provisional matrix (Brooks et al., 1994). Additionally, 
movement into granulation tissue through digestion of the basement membrane is 
promoted via plasmin and collagenase. Both proteases are activated by the action of 
plasminogen activator which is released from endothelial cells upon stimulation with 
bFGF (Clark, 1996; Pintucci et al., 1996). A major regulator of angiogenesis is 
vascular endothelial growth factor (VEGF), which is one of the most potent 
stimulators for endothelial cell proliferation in vitro (Keck et al., 1989). The VEGF 
family currently includes VEGF-A, -B, C, D, E and placenta growth factor (PLGF). In 
fact, VEGF-A is strongly upregulated upon wounding and keratinocytes, together with 
Mφ , are the major producers (Brown et al., 1992; Frank et al., 1995). Reduced VEGF- Introduction 
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A expression or its accelerated degradation are associated with impaired wound 
healing (Frank et al., 1995; Swift et al., 1999; Lauer et al., 2000; Kämpfer et al., 
2001). It has been demonstrated that proinflammatory cytokines can induce 
expression of VEGF in keratinocytes and Mφ  (Frank et al., 1995; Perez-Ruiz et al., 
1999). Additionally, several growth factors, including FGF7, EGF, TGF-α  and 
hepatocyte growth factor (HGF) have been shown to stimulate the production of 
VEGF by cultured keratinocytes (Detmar et al., 1995; Frank et al., 1995; Gille et al., 
1998). Recently, PLGF has been identified as a regulator of wound angiogenesis, 
since PLGF knock-out mice were characterized by impaired wound healing as a 
result of a defect in angiogenesis (Carmeliet et al., 2001). There are several other 
molecules and conditions that mediate angiogenic properties, including IL-8, PDGF, 
biogenic amines and lactic acid as well as low oxygen tension (Folkman and Shing, 
1992; Koch et al., 1992; Battegay et al., 1994; Lane et al., 1994). Resolution of the 
angiogenic process (termination and stabilization of new vessels) is most likely 
regulated via a well-defined homeostasis of pro- and anti-angiogenic mediators 
(Iruela-Arispe and Dvorak, 1997). Factors that are associated with the phase of 
resolution include thrombospondins 1 and 2, angiostatin, endostatin and angiopoietin 
2 (Guo et al., 1997; Folkman, 1997; Holash et al., 1999; Kämpfer et al., 2001). 
 
 
1.2.6   Remodeling 
 
The remodeling of the extracellular matrix and maturation of the neoepidermis, 
fibroplasia, and neovasculature begin at the wound margin while granulation tissue is 
still invading the wound space (Kurkinen et al., 1980). Initially, the extracellular matrix 
is rich in fibronectin but as soon as fibroblasts start their synthesizing activity (see 
1.2.4), collagen becomes the predominant constituent. Subsequently, this randomly 
distributed collagen fibers become cross-linked and aggregate into fibrillar bundles. 
Due to this process the healing tissue gains tensile strength. The matrix alteration is 
due to a well coordinated process of collagen synthesis and collagen degradation 
which is controlled by extracellular collagenases, i.e. matrix metalloproteinases 
(Mignatti, 1996). However, the collagen bundles of scar tissue are organized in 
parallel but not in a basket-weave meshwork as it is typical for unwounded skin. 
Thus, the breaking strength of injured tissue is lower (≤ 70%) compared to intact skin  Introduction 
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(Levenson et al., 1965). Furthermore, lost epidermal appendages do not regenerate, 
nor do nerves or melanocytes (Martin, 1997). 
 
1.3  Nitric oxide and skin  
 
Nitric oxide (NO) is a free radical gas, which has been recognized as a versatile 
player involved in a variety of different physiological and pathophysiological 
processes (Beck et al., 1999; Moncada et al., 1991). The synthesis of NO is 
catalyzed by NO synthases (NOS) which exist in three distinct isoforms: endothelial 
(eNOS), neuronal (nNOS) and inducible NOS (iNOS) (Nathan and Xie, 1994). eNOS 
is mainly expressed in endothelial cells, while nNOS is predominantly present in 
neurons. However, both enzymes have been found in many other cells and tissues 
(Nakane et al., 1993; Gath et al., 1996; Shimizu et al., 1997; Stallmeyer et al., 2002). 
nNOS and eNOS, which are regulated by Ca
2+ fluxes and subsequent binding to 
calmodulin, have been considered to be constitutively expressed proteins 
(MacMicking et al., 1997). However, it turned out that these two isoforms are also 
subject to expressional regulation (Förstermann et al.,1998). By contrast, the 
inducible isoform (iNOS) is expressed upon stimulation by inflammatory cytokines or 
endotoxin in a variety of different cell types (Moncada et al., 1991; Nathan and Xie, 
1994). All three NOS isoenzymes are homodimeric proteins which catalyze the 
oxidation of the amino acid L-arginine to give rise to citrulline and NO. The activity of 
the NO synthases depends on nicotinamide adenine dinucleotide phosphate 
(NADPH), reduced flavins, heme-bound iron, and 6 (R) 5,6,7,8-tetrahydrobiopterin 
(BH4) as essential cofactors (Baeck et al., 1993; Klatt et al., 1993). 
All three NOS isoforms are present in the skin, with respect to different distributions. 
nNOS is reported to be expressed in keratinocytes and melanocytes (Baudouin and 
Tachon, 1996; Romero-Graillet et al., 1996; Boissel et al., in press) while eNOS 
could be detected in keratinocytes of the basal layer, dermal fibroblasts, endothelial 
capillaries, and ecrine glands (Wang et al., 1996; Shimizu et al., 1997). Skin 
keratinocytes, fibroblasts, Langerhans and endothelial cells express iNOS (Wang et 
al., 1996; Bruch-Gerharz et al., 1996; Sirsjo et al., 1996; Qureshi et al., 1996, Kuhn et 
al., 1998). The NOS give rise to NO which is involved in the modulation of the 
microvascular tone and permeability in the skin, the regulation of melanogenesis and 
as a protecting agent against invading pathogens (Bruch-Gerharz et  al., 1998). 
Moreover, the presence of iNOS has been described for inflammatory skin diseases  Introduction 
 
  11
such as psoriasis (Bruch-Gerharz et al., 1996; Frank et al., 2000a), lupus 
erythematosus (Kuhn et al., 1998), inflammatory dermatoses (Rowe et al., 1997), 
and hypersensitivity reactions (Bruch-Gerharz et al., 1998). In fact, NO plays an 
important role throughout the process of wound healing. Yamasaki et al. (1998) 
convincingly showed a functional evidence for iNOS-derived NO during repair. The 
authors demonstrated that a delayed wound closure present in iNOS deficient mice 
could be reversed by adenoviral-mediated expression of human iNOS cDNA. Upon 
wounding, iNOS expression is dramatically induced and persists during inflammation, 
granulation tissue formation and reepithelialization (Frank et al., 1998a). Remarkably, 
iNOS expression is not restricted to PMN and Mφ , as proliferating keratinocytes of 
the wound margins, and to a smaller extent also wound fibroblasts express iNOS 
(Frank  et al., 1998a; Reichner et al., 1999). The observation that proliferating 
keratinocytes of the wound margins strongly express iNOS (Frank et al., 1998a) and 
that this proliferation is decreased by the iNOS inhibitor L-NIL (Stallmeyer et al., 
1999), pointed towards a role of NO to serve as a keratinocyte mitogen. 
Keratinocytes tend to respond to NO in a biphasic manner: increased proliferation is 
mediated by low NO concentrations, while keratinocytes differentiate in the presence 
of high NO concentrations (Krischel et al., 1998). Additionally, NO is linked to 
keratinocyte gene expression, since the important angiogenic factor VEGF (Frank et 
al., 1999) and chemokines (Frank et al., 2000c; Wetzler et al., 2000) have been 
shown to be dependent on the availability of iNOS-derived NO at the wound site. The 
deposition of wound matrix by fibroblasts is likely to be regulated by NO, also, since 
Schaffer et al. (1996) demonstrated that the inhibition of wound NO synthesis is 
paralleled by a decreased wound collagen synthesis. Moreover, an increase in 
collagen accumulation could convincingly be linked to iNOS-derived NO production in 
vivo (Thornton et al., 1998).  
It has been demonstrated that eNOS is also participating in cutaneous healing, since 
eNOS deficient mice are characterized by a delayed excisional wound closure and 
reduced wound breaking strength (Lee et al., 1999). The observed data indicate an 
important role for eNOS-derived NO in extracellular matrix production. Furthermore, 
the authors suggest defects in angiogenesis during repair. Stallmeyer et al. (2002) 
observed a reduced proliferative activity in wound keratinocytes in eNOS deficient 
mice. 
  Introduction 
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1.4 RNA  helicases 
 
RNA helicases are highly conserved and found in all organisms from bacteria to 
humans and in many viruses. The main function of RNA helicases is likely to be the 
unwinding of dsRNA (de la Cruz et al., 1999; Tanner and Linder, 2001) or RNA-
protein complexes (Staley and Guthrie, 1998; Jankowsky et al., 2001; Linder et al., 
2001; Schwer et al., 2001). Biochemical studies revealed that the unwinding occurs 
in an energy-dependent fashion through hydrolysis of nucleoside triphosphate 
(generally ATP) (Lüking et al., 1998). Most RNA helicases belong to superfamily II 
which is subdivided in DEAD (Asp-Glu-Ala-Asp) (Fig. 3) and DExH (Asp-Glu-x-His) 
box families according to consensus sequences in their conserved motifs 
(Wassermann and Steitz, 1991). It is now well established that RNA helicases are 
involved in various aspects of RNA metabolism such as nuclear transcription, pre-
mRNA splicing, ribosome biogenesis, nucleocytoplasmic transport, translation, RNA 
decay, organellar gene expression, and virus propagation (de la Cruz et al., 1999; 
Kadare and Haenni, 1997). For example, the prototypic member of the DEAD-box 
family, the eukaryotic translation initiation factor eIF4A, promotes ribosome binding 
by unwinding the secondary structure in the 5` untranslated region of eukaryotic 
mRNAs (Pause and Sonenberg, 1992, 1993; Pause et al., 1993). In contrast to DNA 
helicases that unwind their substrate in a processive manner (West, 1997), RNA 
helicases are believed to modulate only short duplex regions, generally below 10 bp. 
In general, RNA helicases show very little substrate specificity when analyzed in vitro 
(Kim et al., 1998), a circumstance which seems to be also true for DNA helicases 
(Caruthers et al., 2000; Lin and Kim, 1999).  
 
 
1.4.1 p68 RNA helicase 
 
p68 was initially discovered by a cross-reaction with an antibody against simian virus 
(SV) 40 large T protein (Lane and Hoeffler, 1980). p68 RNA helicase, which is 
encoded by a single gene locus on chromosome 17 in humans, is a prototypical 
member of the DEAD-box family (Ford et al., 1988, Hirling et al., 1989) (Fig. 3).  Introduction 
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AXXGXGKT TPGR DEAD SAT RGXD HRIGRXXR
Helicase-core COOH
IQ
motif
430 554 560 614
H2N
1 134
p68 RNA Helicase
 
Figure 3 Schematic illustration of domain structure of p68 RNA helicase. 
The lower panel represents the helicase-core region of DEAD-box proteins: motifs AXXGXGKT, 
TPGR and DEAD comprise the NTP-binding and hydrolysis domains; SAT motif links NTP hydrolysis 
with unwinding activity; RGXD represents the substrate-binding motif; HRIGRXXR motif binds RNA. 
The IQ domain in the upper panel contains CaM binding and PKC phosphorylation sites (Yang et al., 
2003; modified) 
 
Sequence analysis of p68 cDNA revealed a striking homology to eIF-4A (Ford et al., 
1988) leading to the definition of DEAD box family of proteins (Linder et al., 1989). 
p68 helicase shows ATP-dependent RNA helicase and RNA-dependent ATPase 
activities in vitro (Iggo and Lane, 1989) and is, besides eIF-4A, the second example 
of a DEAD-box RNA helicase that is able to unwind RNA duplexes in a bi-directional 
manner (Pause et al., 1992; Huang and Liu, 2002). p68 RNA helicase is highly 
conserved throughout evolution. Human and murine p68 proteins are 98% identical 
(Lemaire and Heinlein, 1993), and even the Saccharomyces  cerevisiae p68 
homologue shares 55% sequence identity with the human protein (Iggo et al., 1991). 
Moreover, protein function appears to be even more conserved, as the growth defect 
in S. cerevisiae DBP2 null cells could be reversed by human p68 (Bond et al., 2001). 
p68 RNA helicase was shown to be nearly absent in quiescent cells, but dramatically 
induced upon serum treatment implying a functional link between expression and 
proliferation (Stevenson et al., 1998). However, expression levels of p68 protein do 
not always correlate to the proliferation status in adult tissue, although there is 
evidence that p68 expression correlates with organ differentiation and maturation of 
the fetus (Stevenson et al., 1998). Additionally, p68 has been demonstrated to be 
overexpressed in nuclei of epithelial cells under hyperproliferative conditions of 
colorectal adenocarcinoma (Causevic et al., 2001). Immunocytochemical studies 
revealed a granular nuclear staining which is excluded from the nucleoli during 
interphase (Lane and Hoeffler, 1980; Iggo et al., 1989). During late telophase,  Introduction 
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however, p68 was found to co-localize with the nucleolar protein fibrillarin in nascent 
nucleoli (Nicol et al., 2000). Moreover, p68 has been identified as a member of the IQ 
domain-containing family (Buelt et al., 1994). The IQ domain is a 19 amino acid 
sequence, containing a calmodulin (CaM) binding and a protein kinase C (PKC) 
phosphorylation site. Studies with recombinant p68 showed that both Ca
+-dependent 
CaM binding and PKC phosporylation inhibited p68 ATPase function, suggesting a 
possible way of p68 RNA helicase regulation (Buelt et al., 1994). 
 
 
1.5  Aim of the thesis 
 
Nitric oxide (NO) is an important messenger molecule in normal skin biology and also 
diseased skin (Weller, 1999; Bruch-Gerharz et al., 1998). Studies on skin tissue have 
also demonstrated a key function of NO in the process of cutaneous wound healing 
(Frank  et al., 2002). Moreover, NO is known to function as a potent mitogenic 
mediator for keratinocytes in vitro (Krischel et al., 1998; Frank et al., 2000a) and 
during the process of reepithelialization in vivo (Frank et al., 1998a, Stallmeyer et al., 
1999). However, it is particularly not much known about how NO exerts its unique 
actions on keratinocytic cells. To gain further insight into these mechanisms, we 
established and subsequently screened a subtractive keratinocyte cDNA library, 
which was enriched for NO-regulated genes. In fact, we were aiming for new players, 
which could provide the “missing link” between NO and the resulting mitogenic 
response in keratinocytes. We identified p68 DEAD box RNA helicase as a novel 
NO-induced gene in keratinocytes. Published data suggest p68 to play a role in cell 
growth and division (Lane and Hoeffler, 1980; Stevenson et al., 1998; Tanner and 
Linder, 2001). Additionally, p68 is discussed to be involved in transcription (Endoh et 
al., 1999; Watanabe et al., 2001; Rossow and Janknecht, 2003). Due to these 
observations p68 might at least partially contribute to or, moreover, mediate some of 
the well-established actions of NO in keratinocyte biology, such as regulation of gene 
expression and keratinocyte proliferation.  Materials and Methods 
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2 
Materials and Methods 
___________________________________ 
 
2.1 Materials 
 
2.1.1 Chemicals 
 
[α -
32P]UTP  Amersham Pharmacia, Braunschweig 
5-Bromo-4-chloro-3-indolyl-β -D-galactoside  Roth, Karlsruhe 
8-Hydroxyquinoline  Sigma Aldrich Fine Chemicals, Deisenhofen 
Acrylamide/bisacrylamide-solutions Roth,  Karlsruhe 
Actinomycin D  Sigma Aldrich Fine Chemicals, Deisenhofen 
Agar  Gibco Life Technologies, Karlsruhe 
Agarose Biozym,  Oldendorf 
Ammoniumpersulfate  Sigma Aldrich Fine Chemicals, Deisenhofen 
Ampicillin  Sigma Aldrich Fine Chemicals, Deisenhofen 
Aprotinin  Roche Biochemicals, Mannheim 
Aquatex mounting media  Merck, Darmstadt 
Bovine serum albumin  Sigma Aldrich Fine Chemicals, Deisenhofen 
Cell culture media  Gibco Life Technologies, Karlsruhe 
Cycloheximide  Sigma Aldrich Fine Chemicals, Deisenhofen 
DETA NONOate  Calbiochem, Schwalbach 
Diamidino phenylindole  Sigma Aldrich Fine Chemicals, Deisenhofen 
Diethylpyrocarbonate  Sigma Aldrich Fine Chemicals, Deisenhofen 
Dithiothreitol  Sigma Aldrich Fine Chemicals, Deisenhofen 
EDTA  Sigma Aldrich Fine Chemicals, Deisenhofen 
EGTA  Sigma Aldrich Fine Chemicals, Deisenhofen 
Ethidium bromide  Sigma Aldrich Fine Chemicals, Deisenhofen 
Fetal calf serum  Gibco Life Technologies, Karlsruhe 
G418  Gibco Life Technologies, Karlsruhe 
Glutathione  Sigma Aldrich Fine Chemicals, Deisenhofen 
Guanidinium thiocyanate  Sigma Aldrich Fine Chemicals, Deisenhofen 
Hematoxylin solution  Sigma Aldrich Fine Chemicals, Deisenhofen 
Hydroxylammoniumchloride Merck,  Darmstadt 
Isopropylthiogalactoside Roth,  Karlsruhe 
JNK Inhibitor I  Calbiochem, Schwalbach 
Ketamin (-hydrochloride)  Amersham Pharmacia, Braunschweig 
Leupeptin  Roche Biochemicals, Mannheim 
Lipofectamine   Gibco Life Technologies, Eggenstein 
Lipopolysaccharide  Sigma Aldrich Fine Chemicals, Deisenhofen 
L-N
6-(1-iminoethyl)lysine Alexis,  Grünberg Materials and Methods 
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Molecular weight markers (DNA)  MBI Fermentas, St. Leon-Rot 
Molecular weight markers (protein)  Amersham Pharmacia, Braunschweig 
N
G-monomethyl-L-arginine Alexis,  Grünberg 
N-naphtylethylendiamine dihydrochloride  Sigma Aldrich Fine Chemicals, Deisenhofen 
NS 2028  Alexis, Grünberg 
Nucleotide triphosphates  PE Biosystems, Weiterstadt 
ODQ Alexis,  Grünberg 
Oligonucleotides  MWG Biotech, Ebersberg 
Pepstatin A  Roche Biochemicals, Mannheim 
Peptone  Gibco Life Technologies, Eggenstein 
Phenol Roth,  Karlsruhe 
Phenylmethylsulfonyl fluoride  Roche Biochemicals, Mannheim 
Phytohaemagglutinin  Roche Biochemicals, Mannheim 
Ponasterone A  InVitrogen, Groningen, Netherlands 
Ponceau S  Serva, Heidelberg 
RNasin   Promega, Mannheim 
SB 202190  Calbiochem, Schwalbach 
Skim milk (non fat)  Fluka, Deisenhofen 
Sn-Protoporphyrin IX  Alexis, Grünberg 
Sodium nitroprusside  Sigma Aldrich Fine Chemicals, Deisenhofen 
Sodiumlaurylsarcosyl Serva,  Heidelberg 
Spermine-NONOate Calbiochem,  Schwalbach 
Sulfanilamide  Sigma Aldrich Fine Chemicals, Deisenhofen 
Tetramethylethylendiamine  Sigma Aldrich Fine Chemicals, Deisenhofen 
Tissue freezing media  Leica Instruments, Nussloch 
Triton X-100  Sigma Aldrich Fine Chemicals, Deisenhofen 
tRNA, RNase free  Roche Biochemicals, Mannheim 
Trypan blue  Gibco Life Technologies, Eggenstein 
Tween 20  Sigma Aldrich Fine Chemicals, Deisenhofen 
U0126 Calbiochem,  Schwalbach 
Xylazin (-hydrochloride)  Bayer, Leverkusen 
YC-1 Alexis,  Grünberg 
Yeast extract  Gibco Life Technologies, Eggenstein 
 [
35S]methionine- and [
35S]cystein pro mix  Amersham Pharmacia 
α -
32P[CTP]  Amersham Pharmacia, Braunschweig 
β -Mercaptoethanol  Sigma Aldrich Fine Chemicals, Deisenhofen 
 
Acetone, acids, chloroform, ethanol, ether, methanol and isopropanol were from the 
supply store of the Universitätsklinikum Frankfurt. All other, not listed chemicals were 
purchased from Merck (Darmstadt), Roth (Karlsruhe) or Sigma Biochemicals 
(Deisenhofen). 
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2.1.2  Other materials and kits 
 
ECL detection system  Amersham Pharmacia, Braunschweig 
Human VEGF ELISA  R & D Systems, Wiesbaden 
Nanoquant Roth,  Karlsruhe 
NucleoSpin Extrakt 2 in 1  Machery & Nagel, Düren 
PCR-Select
TM cDNA Substraction Kit  Clontech, Heidelberg 
Plasmid Purification kit (Qiagen-tip 100)  Qiagen, Hilden 
siRNA  Qiagen-Xeragon, Germantown, USA 
TNT
R Coupled Reticulocyte Lysate System  Promega, Mannheim 
AdvanTAge PCR Cloning Kit  Clontech, Heidelberg 
NucleotrapR mRNA Kit  Machery & Nagel, Düren 
 
 
2.1.3 Laboratory  equipment 
 
ABI-Prism 310 Genetic Analyser  Applied Biosytems Applera, Weiterstadt 
Circular shaker  Unitron Infors AG, Bottmingen, Switzerland 
Gel dryer 583  Bio-Rad, München 
Gene Quant II  Amersham Pharmacia, Braunschweig 
GeneAmp 2400/9600 Thermocycler  Applied Biosytems Applera, Weiterstadt 
GS Gene Linker  Bio-Rad, München 
Herasafe clean bench  Heraeus, Hanau 
Incubator Heraeus BBD 6220  Heraeus, Hanau 
Microplate reader Benchmark  Bio-Rad, München 
Phosphoimager BAS 1500  Raytest, Straubenhardt 
Trans-Blot SD  Bio-Rad, München 
TRI-CARB 2100 TR β -counter  Canberra-Packard, Dreieich 
UltraTurrax IKA,  Staufen 
Zeiss LSN 510 META  Zeiss, Jena 
 
 
2.1.4 Enzymes 
 
Alkaline phosphatase  Roche Biochemicals, Mannheim 
Pfu-DNA polymerase   Stratagene, Heidelberg 
Proteinase K  Roche Biochemicals, Mannheim 
Restriction enzymes  MBI-Fermentas, St. Leon-Rot 
  Roche Biochemicals, Mannheim; 
   Stratagene, Heidelberg; 
Reverse transcriptase  Gibco Life Technologies, Eggenstein 
RNA polymerase T3 and T7  Roche Biochemicals, Mannheim 
RNase A and T1  Roche Biochemicals, Mannheim 
T4-DNA ligase  Roche Biochemicals, Mannheim 
Taq-DNA polymerase  Roche Biochemicals, Mannheim Materials and Methods 
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2.1.4.1  Pretreatment of enzymes  
 
Proteinase K 
The lyophilized enzyme was dissolved in Aquadest (10 mg/ml), incubated for 30 min at 
37°C and aliquoted. The aliquots were stored at –20°C until use. 
 
RNase A 
RNase A was dissolved to a final concentration of 10 mg/ml in RNase-buffer 
[Tris/HCl (10 mM, pH 7.5), NaCl (15 mM)]. The enzyme solution was incubated for 30 
min at 95°C and cooled to room temperature over night. Aliquots were stored at –
20°C until use. 
 
 
2.1.5  Antibodies and antisera 
 
anti-human C23/ Nucleolin (mouse, monoclonal)  Santa Cruz Biotechnologies, Heidelberg 
anti-green fluorescent protein (mouse, monoclonal)  Roche Biochemicals, Mannheim 
anti-murine Ki-67 (rabbit, polyclonal)  Dianova, Hamburg 
anti-human PCNA (rabbit, polyclonal)  Santa Cruz Biotechnologies, Heidelberg 
anti-human p68 (rabbit, polyclonal)  Eurogentec, Belgium 
anti-mouse IgG (FluoroLink
TMCy
TM3 labelled)  Amersham Pharmacia, Freiburg 
anti-mouse IgG (horseradish-peroxidase coupled)  Pierce, Rockford, USA 
anti-rabbit IgG (horseradish-peroxidase coupled)  Dianova, Hamburg 
 
 
2.1.6  Recombinant and purified proteins 
 
EGF  Roche Biochemicals, Mannheim 
IFN-γ  (human)  PeproTech, Frankfurt 
IFN-γ  (human)  Roche Biochemicals, Mannheim 
IL-1β   Roche Biochemicals, Mannheim 
KGF  Roche Biochemicals, Mannheim 
TGF-α   Roche Biochemicals, Mannheim 
TGF-β   Roche Biochemicals, Mannheim 
TNF-α   Roche Biochemicals, Mannheim 
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2.1.7 Plasmids 
 
2.1.7.1 Vectors 
 
pBluescript II KS (+)  Stratagene, Heidelberg 
pcDNA3.1 (+)  InVitrogen, Groningen, Netherlands 
pEGFP-N1  Clontech Laboratories, Heidelberg 
 
 
2.1.7.2 Recombinant  plasmids 
 
pBKS(+)p68 (human, nucleotides 1891-2161)  Hloch et al. 1990; Acc.No.NM_004396 
pBKS(+)p68 (murine, nucleotides 551-785)  Lemaire and Heinlein, 1993 
pBKS(+)GAPDH (human, nucleotides 148-302)  Tokunaga et al. 1987 
pBKS(+)GAPDH (murine, nucleotides 128-282)  Sabath et al. 1990 
pBKS(+)VEGF (human, nucleotides 339-498)  Weindel et al. 1992 
pcDNA3.1 (+)p68 (human, nucleotides 169-2018)  Hloch et al. 1990; Acc.No.NM_004396 
pEGFP-N1p68 (human, nucleotides 169-2012)  Hloch et al. 1990; Acc.No.NM_004396 
pBKS(+)PFK (human, nucleotides 487-742)  Simpson and Fothergill-Gilmore, 1991 
 
 
2.1.8 Bacterial  strains 
 
E. coli XL-1 blue  Stratagene, Heidelberg 
 
 
2.1.9  Eukaryotic cell lines 
 
HaCaT  Human adult keratinocytes [Boukamp et al. 1988] 
HEK 293  kindly provided by H. Radeke, Frankfurt 
PAM 212  Epidermal keratinocytes 
pcDNA3.1p68  p68 RNA Helicase  overexpressing HaCaT cells  
RAW 264.7 
 
 
Mouse macrophages (American Type Tissue Collection, 
Rockville, USA) 
2.1.10 Buffers 
 
PBS-buffer 10fold  1,5 M NaCl, 30 mM KCl, 15 mM KH2PO4,  
60 mM Na2HPO4 
TAE-buffer 10fold  400 mM Tris acetate, 10 mM EDTA 
TBE-buffer 10fold  900 mm Tris borate, 20 mM EDTA 
SSC-buffer 20fold  3 M NaCl, 300 mM Na2Citrat 
 
All buffers were prepared with highly purified water from a Milli-Q-system (Millipore). 
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2.1.11 S-nitroso-glutathione 
 
Glutathione was dissolved in 0.625 N HCl at 0°C to a final concentration of 625 mM. 
NaNO2 was added in an equimolar amount and the mixture was stirred at 0°C for 40 
min. After the addition of 2.5 volumes of acetone stirring went on for additional 20 
min, followed by filtration of the precipitate. GSNO was washed once with 80% 
acetone, two times with 100% acetone, and finally three times with diethylether and 
dried under vacuum. The powder was aliquoted in Eppendorf tubes and stored at –
20°C until use. 
 
 
2.1.12 Computer Software 
 
DNA/protein homology search  BLAST search (National Center of Biotechnology, 
USA; URL: http://www.ncbi.nlm.nih.gov) 
 
Graphic processing  Corel Draw 8.0 and 10.0 
Presentations PowerPoint  2000 
Statistical analysis  Sigma Plot 4.0 
Text processing  Microsoft Word 2000 
 
Programs belonging to special devices are mentioned separately in the appropriate 
sections. 
 
 
2.2 Bacterial  culture 
 
The E. coli strain XL1-blue (Stratagene) was used for amplification of plasmid DNA. 
Bacteria were grown in liquid LB (Lauria-Bertani) medium (1% bacto-tryptone w/v, 
0,5% bacto-yeast-extract w/v and 1% NaCl w/v). For selection, the media contained 
ampicillin or kanamycin (50 µg/ml). Agar-plates were generated with LB-ampicillin or 
-kanamycin medium supplemented with agar (15 g/l). For long-term preservation of 
transformed bacteria (2.2.2), cells were mixed with sterile glycerol [30% (v/v)] and 
stored at –20°C. 
 
 
2.2.1  Competent bacteria for transformation 
 
To yield high transformation efficiencies from plasmid DNA in bacteria, cells have to 
be pretreated chemically. To this end, 100 ml LB-Medium were inoculated with 200 µl Materials and Methods 
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of an overnight bacterial culture and grown at 37°C until the suspension reaches an 
optical density of 0.5 (OD600). Bacterial cells were concentrated by centrifugation (15 
min, 4000 rpm, 4°C; Heraeus Megafuge 1.0, rotor 7570F). The cellular pellet was 
subsequently resuspended in 33 ml solution A, mixed and incubated on ice for 45 
min. The bacterial suspension was centrifuged again (15 min, 4000 rpm, 4°C), the 
pellet was gently resuspended in 9 ml of solution B and incubated on ice for 
additional 15 min. Aliquots of competent bacteria were snap frozen in liquid nitrogen 
and stored at –80°C. 
 
Solution 
components 
Solution A 
(sterile filtrated) 
Solution B 
(sterile filtrated) 
 RbCl  100  mM  10  mM 
 MnCl2 50  mM  --- 
 CaCl2 10  mM 75  mM 
 KOAc  30  mM  --- 
  Glycerol   15% (v/v)  15% (v/v) 
 MOPS  ---  10  mM 
 
 
Transformation 
 
100 µl of a competent bacteria suspension (2.2.1) were thawed on ice and 10 µl of 
the ligation reaction (2.3.6.2) was added. The bacteria/DNA mixture remained on ice 
for additional 30 min followed by an incubation at 42°C for 3 min. The bacteria were 
chilled on ice again for 2 min, before 300 µl of LB-medium were added. For initial 
expression of the plasmid encoded ampicillin resistance, bacteria were incubated for 
45 min at 37°C on a circular shaker. Subsequently, 100 µl of this transformation 
solution were plated on ampicillin containing agar plates. To enable a blue/white 
screening for recombinant clones, the agar plate was supplemented with 100 µl X-
Gal (2% w/v in DMF) and 40 µl IPTG (0.1 M in Aquadest). The plates were incubated 
overnight at 37°C. 
 
 
2.3  Nucleic acid techniques 
 
2.3.1  Preparation of plasmid DNA 
 
Plasmids have been routinely isolated from bacterial cultures using a modified 
protocol originally described by Birnboim and Doly [1979]. 3 ml of medium containing 
the appropriate antibiotic(s) were inoculated with a single bacterial colony from a Materials and Methods 
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selective agar plate and incubated overnight by vigorous shaking at 37°C. 1.5 ml of 
the cell-suspension was centrifuged for 2 min at 7000 x g, and the medium was 
removed carefully by aspiration. The bacterial pellet was resuspended in 100 µl of 
solution I. Subsequently, 200 µl of freshly prepared solution II were added to the 
dispersed bacteria, mixed five times by inverting the tubes and stored on ice for 
exactly five minutes. This step lyses the bacterial cells and denatures the DNA. The 
lysate was neutralized by 150 µl acidic potassium buffer (solution III), which was 
gently mixed after addition and stored on ice for additional 10 minutes. The high salt 
concentration causes SDS to precipitate, and the denatured proteins, cellular debris 
and chromosomal DNA become trapped by salt-detergent complexes. Plasmid DNA, 
being smaller and covalently closed, renatures correctly and remains in solution. The 
tube was centrifuged for 10 min at 15,000 x g and the supernatant containing the 
plasmids transferred to a new Eppendorf tube. A subsequent cleaning step using 
phenol/chloroform was performed optionally, as trace amount of phenol could disturb 
subsequent enzymatic reactions processing the plasmid-DNA. Plasmid-DNA was 
precipitated using 2 volumes of ethanol at room temperature and a centrifugation 
step for 10 min at 15,000 x g. The pellet was air dried for 10-15 min and the DNA 
was finally dissolved in 15 µl of Aquadest.  
High amounts of pure plasmid DNA (up to 100 µg) were prepared using the QIAGEN 
Plasmid Midi Kit as described by the manufacturer. 
 
 
Solution 
components 
Solution 
I 
Solution 
II 
Solution 
III 
Glucose 50  mM  ---  --- 
Tris/HCl (pH 8.0)  25 mM   ---  --- 
EDTA (pH 8.0)  10 mM  ---  --- 
NaOH ---  200  mM  --- 
SDS ---  1%  --- 
KOAc (pH 5.5, adjusted 
with glacial acetic acid) 
--- ---  3  M 
 
 
2.3.2 RNA  isolation 
 
2.3.2.1  Isolation from cultured cells 
 
RNA isolation was performed according to a protocol from Chomczynski and Sacchi 
(1987). Cells were grown and stimulated as described in 2.5.1. Cells were washed 
twice with PBS and last traces of PBS were removed by a pipette tip attached to a Materials and Methods 
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vacuum line. Subsequently, cells were lysed with 400 µl of GSCN-solution per 10 cm-
plate, scraped with a rubber policeman and the lysate was transferred into an 
Eppendorf tube. After addition of 40 µl 2 M NaOAc (pH 4.0), 400 µl acidic phenol 
(H2O-saturated) and 120 µl chloroform, the samples were vortexed vigorously for 20 
sec. The vortexed tubes were stored 15 minutes on ice, centrifuged (15,000 g, 10 
min) and the aqueous upper phase was transferred into a fresh tube. RNA was 
precipitated using 1 ml of EtOH, and isolated by a single centrifugation step (15,000 x 
g, 10 min). The RNA pellet was dissolved in DEPC-treated water, followed by an 
additional phenol/chloroform (pH 9.5, 1M Tris/HCl saturated) extraction. After 
centrifugation (15,000 x g, 10 min), the RNA was finally precipitated form the 
aqueous phase by addition of 40 µl 3 M NaOAc (pH 5.2) and 1 ml ethanol. The 
samples were centrifuged (15,000 x g, 10 min) and the final RNA pellet was 
resuspended in 200 µl DEPC-treated water. Following a 10 min incubation at 65°C, 
the amount of isolated RNA was quantified photometrically (2.3.3). 2 µg of the 
isolated RNA was controlled for integrity by agarose gel electrophoresis (1.5%, 1 x 
TAE buffer). Finally, RNA was aliquoted and stored in ethanol at -20°C until use. 
 
Solution 
components 
GSCN- 
solution 
Guanidinium 
thiocyanate 
50% (w/v) 
Sodiumlaurylsarcosyl 0.5%  (w/v) 
Sodiumcitrate, pH 7.0  15 mM 
β -Mercaptoethanol 0.7%  (v/v) 
 
 
2.3.2.2  Isolation from tissue 
 
Skin samples (murine wounds) were homogenized in Falcon tubes using an 
UltraTurrax (IKA Labortechnik) in 4 ml of GSCN-solution. Homogenates were cleared 
by a centrifugation step (4000 rpm, 10 min; Heraeus Megafuge 1.0, rotor 7570F). 
Subsequently, RNA was isolated from the supernatants as described in section 
2.3.2.1. 
 
 
2.3.3  Quantification of nucleic acid concentrations 
 
Concentrations of nucleic acids were determined photometrically using a wavelength 
of 260 nm (Gene Quant II, Amersham Pharmacia). An optical density (OD) of 1 Materials and Methods 
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corresponds to approximately 50 µg/ml double-stranded DNA or 40 µg/ml for single 
stranded DNA and RNA (Sambrook et al. 1989). The ratio between the readings at 
260 nm and 280 nm (OD260/OD280) provides an estimation of the purity of the nucleic 
acid preparation. Highly pure DNA or RNA are characterized by ratios between 1.8 
and 2.0. Low amounts of DNA were estimated by agarose gel electrophoresis (2.3.4) 
in comparison with a known standard concentration. 
 
 
2.3.4  Agarose gel electrophoresis of nucleic acids 
 
Nucleic acids were separated by gel electrophoresis using agarose gels. The 
agarose concentration was dependent on the molecular weight of the analyzed 
nucleic acids. For separation of DNA molecules from 0.5 to 2 kbp usually 1% 
agarose gels (w/v) were used. Smaller DNA fragments (100-500 bp) were separated 
in high density gels (1.5-2% agarose gels) (Sambrook et al., 1998). Agarose 
(Biozym) was dissolved in 1x TAE gel electrophoresis buffer. Ethidium bromide was 
added to a final concentration of 500 ng/µl. Ethidium bromide binds to DNA or RNA 
by intercalation between the bases and, thus enables an ultraviolet fluorescence 
illumination of nucleic acids. The DNA/RNA probes were diluted with loading buffer 
[6x loading buffer: 30% glycerol (v/v), 0.25% bromophenol blue (w/v), 0.25% 
xylenecyanole (w/v), 60% 10x TAE buffer (v/v)] and transferred into the appropriate 
gel wells. Electrophoresis was performed in 1x TAE buffer with a voltage of 5-10 
V/cm gel. DNA fragment sizes were estimated using molecular weight markers (MBI 
Fermentas). 
 
 
2.3.4.1  DNA isolation from agarose gels 
 
The use of the NucleoSpin Extract 2 in 1 Kit (Macherey & Nagel) enables a pure 
extraction of DNA fragments directly from agarose gels. The system is based on a 
silica matrix, which binds single and double stranded DNA. The DNA fragments of 
interest were cut from the gel with a razor blade and further processed to the 
instructions of the manufacturer. 
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2.3.5  Reverse transcriptase polymerase chain reaction 
 
2.3.5.1 Reverse  transcription 
 
The enzyme reverse transcriptase, originally discovered in RNA tumor viruses, 
synthesizes a complementary DNA strand using RNA as a template. This enzymatic 
activity provides access to the generation of cDNA. In general, eukaryotic mRNAs 
are characterized by a series of adenine nucleotides at the 3´-end, the so called poly-
(A) tail. Through hybridization with oligo-(dT) primers, these poly-(A) sites are ideal 
start points for the reverse transcriptase enzyme. Additionally, random hexamers (50 
ng/µl) were used as internal enzyme start sites. 
 
Reverse transcriptase reaction:  7 µl  RNA (0.5 µg/µl) 
1 µl  oligo-(dT) primer (0.5 µg/µl) 
4 µl  5x reverse transcriptase buffer 
2 µl  DTT (0.1 M) 
1 µl  RNasin (Promega) 
4 µl  dNTP-mix  
(dATP, dCTP, dGTP, dTTP; 
10mM) 
1 µl  superscript II enzyme (200 
units/µl, Gibco Life Technologies) 
 
7 µl of total RNA (0.5 µg/µl) were mixed with 1 µl oligo-(dT) primer (0.5 µg/µl) and 
incubated for 10 min at 70°C. The tube was chilled on ice and the reagents were 
added as listed in the table. The reaction was performed for 1 h at 37°C. The mix 
was terminated by incubation for 5 min at 95°C, and aliquots of the cDNAs were 
stored at –20°C. 
 
 
2.3.5.2  Polymerase chain reaction (PCR) 
 
This methods enables the in vitro amplification of DNA fragments without time 
consuming cloning and identification steps (Mullis & Foloona, 1987). The method is 
based on the availability of heat-stable DNA polymerases which allow multiple 
denaturing of template DNA, annealing of driver sequences (primer) and synthesis of 
DNA by amplification steps within one tube. 
 
Polymerase chain reaction:  3 µl    cDNA (2.6.5.1) or 
  X µl    Plasmid-DNA (5-10 ng)  
5 µl    10x taq-buffer (containing Mg
2+) Materials and Methods 
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4 µl    dNTP-mix  
(dATP, dCTP, dGTP, dTTP; 5 mM) 
5 µl    forward/reverse primer-mix (10 µM) 
1 µl    taq-polymerase (1 unit) 
                                          ad  50µl    H2O 
 
The reaction was performed in a thermocycler (GeneAmp 2400 or 9600, PE 
Biosystems) with 25-30 cycles of the following steps: 1 min 94°C, 1 min 52°C and 1 
min 72°C. The amplification was completed by a final 10 min incubation step at 72°C. 
Depending on special conditions of the template or the primers the protocol was 
adapted individually. The samples were stored at 4°C and analyzed by gel 
electrophoresis. 
For amplification of the p68 RNA helicase open reading frame, the Pfu polymerase 
(Stratagene) was chosen. In contrast to Taq polymerase (Roche Biochemicals), this 
enzyme exhibits 3`- to 5`-exonuclease proofreading activity. The reaction was 
performed in a thermocycler (GeneAmp 2400 or 9600, PE Biosystems) with 28 
cycles of the following steps: 1 min 94°C, 1 min 59°C and 4 min 72°C. A final 
extension at 72°C for 10 minutes completed the reaction. 
 
 
2.3.5.3  Cloning of PCR products 
 
After amplification, PCR products were separated by gel electrophoresis. The band 
of the appropriate size was cut out and subsequently re-amplified by Pfu-polymerase 
(Stratagene). Once again PCR product was purified by gel electrophoresis and 
isolated from the agarose gel using a column gel extracting kit (Macherey & Nagel). 
Finally, DNA of interest was ligated into pBluescript II (+) KS vector (Statagene) at 
the EcoRV restriction site as described in 2.3.6.2. 
 
 
2.3.6  Manipulation of DNA 
 
2.3.6.1 Restriction 
 
Type II endonucleases isolated from bacteria specifically bind palindromic sequences 
with a subsequent cleavage of the DNA molecule at their recognition site. This 
process generates either blunt-end fragments or overhanging cohesive ends, which 
allow the generation of recombinant DNA by enzymatic ligation. The standard Materials and Methods 
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approach for DNA digestion is subsequently listed. After incubation at the appropriate 
temperature, DNA cleavage was checked by agarose gel electrophoresis (2.3.4). 
 
DNA restriction:  10.0 µl    DNA (500 ng) 
2.0 µl    10 x buffer 
0.2 µl    restriction enzyme (3 units) 
ad 20 µl    H2O 
 
 
2.3.6.2 Ligation 
 
Generation of covalent phosphodiester bonds between the 5´-phosphate and the 3´-
OH of DNA fragments is catalyzed by T4-DNA ligase. The ligation reaction was 
performed with restricted or PCR amplified DNA. The DNA was separated in a   
agarose gel. Subsequently the DNA of interest was isolated using a column gel 
extracting kit by (Macherey & Nagel). The gel extracted fragment was added to the 
ligation reaction. The mixture was incubated for at least 5 h at room temperature. 
Afterwards, an aliquot of this reaction was transformed into competent bacteria as 
described in section 2.2.2. 
 
DNA ligation:  4 µl    10 x ligase buffer 
1 µl    vector DNA (500 ng) 
10 µl    Gel-extracted DNA fragment 
(5 µg) 
1 µl    T4-DNA ligase (1 unit) 
ad 40 µl    H2O 
 
 
2.3.6.3 Dephosphorylation 
 
If the vector DNA carried identical cohesive termini after enzymatic restriction, the 
plasmid was treated additionally with alkaline phosphatase (Roche Biochemicals) 
prior to ligation. Phosphatases remove the 5´-phosphates from DNA strands. This 
technique prevents a re-ligation of restricted plasmids without incorporation of insert 
DNA. To this end, the restricted DNA was incubated with alkaline phosphatase (0.1 
unit/µg DNA) for 30 min at 37°C. Afterwards, the phosphatase was heat-inactivated 
for 10 min at 70°C and the denatured protein extracted with phenol/chloroform. The 
ligation of the DNA fragments was performed as described in 2.3.6.2. 
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2.3.6.4 Cloning  pcDNA-p68 
 
The human p68 RNA helicase cDNA (Acc.No. NM_004396) was cloned from HaCaT 
keratinocytes using 5´-CCA TGT CGG GTT ATT CGA GTG ACC-3´ as a 5´-primer 
and 5´-GTC TTA TTG GGA ATA TCC-3´ as a 3´-primer. The Pfu-amplified PCR 
product corresponded to nucleotides 169 to 2018, including 2 nucleotides upstream 
the ATG start codon and 3 nucleotides downstream the TAA stop codon. The blunt-
end 1849 bp p68 RNA helicase cDNA was cloned into the EcoRV restriction site of 
the pBluescript II KS (+) vector (Stratagene). To verify the correct sequence, both 
strands were sequenced. Subsequently, the p68 RNA helicase cDNA was subcloned 
into the pcDNA3.1(+) expression vector by BamHI/HindIII sites. 
 
 
2.3.6.5 Cloning  pEGFP-N1-p68 
 
The human p68 RNA helicase cDNA (Acc.No. NM_004396) was cloned from HaCaT 
keratinocytes using 5´-CCA TGT CGG GTT ATT CGA GTG ACC-3´ as a 5´-primer 
and 5´-TTG GGA ATA TCC TGT TGG-3´ as a 3´-primer. The Pfu-amplified PCR 
product corresponded to nucleotides 169 to 2012, starting 2 nucleotides upstream 
the ATG start codon, ending 3 nucleotides upstream the TAA, thus missing the stop 
codon. The blunt-end 1846 bp p68 RNA helicase cDNA was cloned into the EcoRV 
restriction site of the pBluescript II KS (+) vector (Stratagene). To verify the correct 
sequence, both strands were sequenced. Subsequently, the p68 RNA helicase cDNA 
w/o stop was subcloned in frame into the pEGFP-N1 expression vector using 
compatible HindIII/XbaI sites and HindIII/NheI sites. 
 
 
2.3.7 DNA  sequencing 
 
DNA sequencing was performed using the ABI-Prism 310 Genetic Analyser (PE 
Biosystems) based on the dideoxynucleotide chain termination method [Sanger et al. 
1977]. In the termination labeling mix, the four dideoxy terminators (ddNTPs) were 
tagged with different fluorescent dyes. This technique allows the simultaneous 
sequencing of all four reactions (A, C, G, T) in one reaction tube. The probes were 
separated electrophoretically using a micro capillary. As each dye terminator emits 
light at a different wavelength when excited by laser light, all four colors 
corresponding to the four nucleotides can be detected and distinguished within a Materials and Methods 
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single run. Raw data were evaluated by the Abi Prism sequencing analysis software 
on a Power G3 Macintosh computer. The sequencing reaction, as listed in the table, 
was performed in a thermocycler (GeneAmp 2400, PE Biosystems) with 25 cycles of 
the following temperature steps: 96°C for 10 sec, 55°C for 5 sec, 60°C for 2 min. For 
the detection process, probes were prepared as described by the manufacturer. 
 
DNA sequencing:  1 µl  DNA (250 ng plasmid DNA 
or 50 ng PCR derived DNA) 
2 µl  sequencing premix 
1 µl  primer (5 pmol) 
6 µl  H2O 
 
 
2.3.8  RNase protection assay 
 
This method was used to quantify the amounts of specific RNA transcripts from total 
cellular RNA. Compared to Northern blot analysis, this technique possesses an 
increased sensitivity and specificity. The assay is based on the principle that double 
stranded RNA hybrids are protected from cleavage by RNases A and T1. 
 
 
2.3.8.1  Preparation of a radiolabeled antisense probe  
 
The desired probes (150-450 nt in length) were cloned into the transcription vector 
pBluescript II KS (+) as described in section 2.6.6. The recombinant plasmids (see 
2.1.5.2) were linearized with restriction enzymes, phenol/chloroform extracted, 
precipitated and dissolved in Aquadest to a final concentration of 1 µg/µl. A pure single 
stranded, [α -
32P] UTP radiolabeled antisense transcript was synthesized using T3 or 
T7 RNA polymerase. The reaction mix was prepared as listed in the table and 
incubated for 1 h at 37°C. 
 
In vitro transcription:  1.1 µl  H2O, DEPC-treated 
  1.0 µl  nucleotides (ATP, CTP, GTP; each 5 mM)  
  2.0 µl  transcription buffer (5 x) 
  0.4 µl  RNasin (40 U/µl) 
  1.0  µl  T3 or T7 RNA polymerase, depending on the 
vector 
 2.5  µl  [α -
32P] UTP (800 Ci/mM) 
  1.0 µl  linearized template (1 µg/µl) 
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Subsequently 90 µl DEPC-H2O were added. The reaction was extracted with an 
equal volume of phenol/chloroform and centrifuged (15,000 x g, 2 min). The 
radiolabeled RNA was precipitated form the aqueous phase using 40 µl of 7.5 M 
ammoniumacetate, 1.5 µl of tRNA (10 µg/µl) and 350 µl of ethanol for 15 min at –
20°C. Following a 15 min centrifugation step at 4°C, the radiolabeled pellet was 
dissolved in 20 µl FLB 80 and purified using an acrylamide/urea gel (5% 
acrylamide/bisacrylamide, 29:1; 8 M urea; 1x TBE). Electrophoresis (1x TBE buffer, 
300 V) was terminated after 90 min. The radiolabeled probe was located by 
autoradiography, cut out and eluated into 300 µl elution buffer (0.1x TBE, 0.2% SDS). 
The incorporated activity of the freshly prepared radiolabeled probe was determined 
using a β -counting device (TRI-CARB 2100 TR, Canberra-Packard). 
 
Buffer 
components 
FLB 80 
buffer 
FAB 
buffer 
RNase 
buffer 
Formamide 
(deionized) 
80% (v/v)  80% (v/v)  --- 
EDTA (pH 8.0)  1 mM  1 mM  5 mM 
PIPES (pH 6.4)  ---  40 mM  --- 
NaCl ---  400  mM  --- 
NaOAc (pH 7.0)  ---  ---  300 mM 
Tris/HCl (pH 7.5)  ---  ---  10 mM 
TBE (1 x)  0.01% (w/v)  ---  --- 
Bromophenol blue  0.05% (w/v)  ---  --- 
Xylenecyanole 0.05%  (w/v)  ---  --- 
 
 
2.3.8.2  Hybridization and cleavage 
 
10-30 µg of total RNA from cell culture or animal experiments (see 2.6.2) were used 
for the experiments. Total RNA and 100,000 cpm of the radiolabeled probe were co-
precipitated using a 2.5-fold excess of ethanol/0.1 M NaOAc. The samples were 
incubated at –20°C for 15 min and subsequently centrifuged (15,000 x g, 10 min). 
The supernatants were removed and the RNA/antisense probe pellet was 
resuspended carefully in 30 µl FAB hybridization buffer. Samples were subsequently 
denatured for 10 min at 85°C and hybridized overnight (42°C in a water bath). 
Following hybridization, samples were treated with 300 µl RNase T1/A-mix (RNase 
buffer supplemented with 10 µg of RNase A and 200 units of RNase T1) for 1 h at 
30°C  [ Melton  et al. 1984] . Under these conditions, every single mismatch was 
recognized by the RNases. RNases were inactivated by an addition of 6.6 µl SDS Materials and Methods 
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(10%) and 4.4 µl proteinase K (10 µg/ml) for 15 min at 42°C. The samples were 
extracted with phenol/chloroform and centrifuged (15,000 x g, 2 min). Protected 
double-stranded RNA hybrids were precipitated using 880 µl of ethanol and 1.5 µl of 
tRNA (10 µg/µl). After centrifugation, (15,000 x g, 15 min), the pellet was 
resuspended in 25 µl FLB 80 buffer, heated for 5 min at 95°C and loaded on the gel. 
 
 
2.3.8.3  Analytical gel electrophoresis and signal detection 
 
The protected RNA fragments were separated on acrylamide/urea gels (5% 
acrylamide/bisacrylamide, 29:1; 8 M urea; 1x TBE). 1000 cpm of the radiolabeled 
antisense probe served as a size marker. Electrophoresis (300 V, 1x TBE buffer) was 
stopped after 60 min. The gel was fixed on Whatman 3MM paper and subsequently 
dried on a gel drying system (Bio Rad). The radiolabeled gel was exposed to a 
phosphoimager plate (BAS-MP 2040S, Fuji) and analyzed using a Fuji 
Phosphoimager BAS-1500. To permit appropriate statistical analysis, all protection 
assays were carried out with at least three different sets of RNA from independent 
cell culture or animal experiments. 
 
 
2.3.9  Differential screening of a subtractive library 
 
Subtractive hybridization represents a technique by which two different populations of 
mRNA can be compared. We have chosen this approach to discover genes that are 
differentially expressed in HaCaT keratinocytes by nitric oxide treatment. The PCR-
Select cDNA Subtraction Kit and the AdvanTAge PCR Cloning Kit (Clontech) were 
used. 
 
 
2.3.9.1  PCR-Select cDNA subtraction 
 
HaCaT cells were stimulated with 500 µM GSNO for 5 hours. RNA was isolated, 
enriched for mRNA (Nucleotrap
R mRNA Kit, Macherey & Nagel) and subsequently 
used as starting material for PCR-Select cDNA subtraction. Subtraction was 
performed according to the instructions of the manufacturer (Clontech). Briefly, cDNA 
was synthesized from 2 µg of mRNA from the GSNO [500 µM] stimulated and 
unstimulated HaCaT cells. The resulting cDNAs were subdivided into two fractions, 
and ligated to different cDNA adaptors, respectively. The adaptor molecules differ in Materials and Methods 
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their PCR primer annealing sequence. In the next step, an excess of cDNA from 
control HaCaT cells was added. Both fractions were denatured and subsequently 
hybridized. Finally, the ends were filled by DNA polymerase and differentially 
expressed sequences were amplified by PCR. Only the cDNAs with two different 
annealing sites were amplified exponentially. These molecules represent the 
differentially expressed sequences. To reduce background PCR products and to 
further enrich differentially expressed sequences, a secondary PCR amplification 
was performed using nested primers. 
 
 
2.3.9.2  Subtracted cDNA Library Construction 
 
3 µl of the secondary PCR product were cloned using the AdvanTAge PCR Cloning 
Kit, a T/A-based cloning system from Clontech. Thermostable polymerases (2.3.9.1) 
synthesize PCR products, that contain a single unencoded deoxyadenosine at their 
3`ends. Those products can be easily ligated to pT-Adv vectors, possessing 3`T-
overhangs. The ligation products were subsequently transformed into competent E. 
coli. 
 
 
2.3.9.3 Colony  Array 
96 bacterial colonies were picked randomly and grown in 100 µl LB-amp medium in a 
96-well plate at 37°C with shaking over night. Nylon membranes were placed onto 
LB/agar plates containing ampicillin. From each bacterial culture 2 x 1 µl were 
transferred onto membranes using a multi-channel pipettor. The membranes were 
generated in duplicates. After incubation at 37°C overnight, the colonies were 
prepared for filter screening. For this purpose, membranes were placed onto 
Whatman 3MM paper saturated with denaturing solution (0,5 M NaOH, 1,5 M NaCl). 
After 4 minutes membranes were neutralized (0,5 M Tris-HCl [pH 7.4], 1,5 M NaCl). 
Finally, membranes were allowed to air dry and DNA was fixed by incubation at 80°C 
for 1-2 hours. 
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2.3.9.4  Preparation of [αααα -
32P]dCTP labeled probe 
 
4 µl of mRNA (0.5 µg/µl) were mixed with 1 µl oligo-(dT) primer (0.5 µg/µl) and 
incubated at 70°C for 10 minutes. The tubes were chilled on ice and reagents were 
added as listed in the table. Reverse transcription was performed at 37°C for one 
hour and terminated by an incubation at 95°C for 5 minutes. Samples were treated 
with 80 µl RNase T1/A-mix (RNase buffer supplemented with 3 µg of RNase A and 
80 units of RNase T1) at 30°C for one hour [ Melton  et al. 1984] . Probes were 
extracted with 100 µl phenol/chloroform and centrifuged (15,000 x g, 2 min). To purify 
probes from unincorporated dNTPs, 40 µl of 7.5 M ammoniumacetate, 2 µl of tRNA 
(10 µg/µl) and 350 µl of ethanol were added. Samples were stored at -20°C for 15 
minutes and subsequently centrifuged (15,000 x g, 4°C, 15 min). The radiolabeled 
pellet was dissolved in 200 µl of Aquadest and activity of each probe was determined 
using a β -counting device (TRI-CARB 2100 TR, Canberra-Packard). 
 
 Reverse transcriptase reaction:  4 µl  Poly A
+ RNA (0.5 µg/µl) 
1 µl  oligo-(dT) primer (0.5 µg/µl) 
4 µl  5x reverse transcriptase buffer 
2 µl  DTT (0.1 M) 
1 µl  Rnasin (Promega) 
1 µl  dATP 
1 µl  dGTP 
1 µl  dTTP 
2,5 µl  [α -
32P]dCTP (3000 Ci/mM) 
1 µl  superscript II enzyme (200 units/µl 
Gibco Life Technologies) 
                                               ad   20 µl  H2O 
 
 
2.3.9.5 Hybridization 
 
[
32P]-labeled probes were hybridized to the subtracted clones on nylon membranes. 
Each membrane was pre-hybridized in 30 ml pre-hybridization solution (7% SDS w/v, 
1% BSA w/v, 0.5 M Na-phosphate buffer, pH 7.2, 1mM EDTA) at 68°C for 2 hours. 
Membranes were transferred into 5 ml of hybridization solution (prehybridization 
solution containing 1x 10
5 cpm probe per milliliter). Hybridization was performed at 
68°C overnight. Membranes were washed with low stringency (2x SSC, 0,5% SDS) 
and high stringency (0,2x SSC, 0,5% SDS). Finally, membranes were exposed to a 
phosphoimager plate (BAS-MP 2040S, Fuji) overnight, and subsequently analyzed. Materials and Methods 
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2.4  Protein techniques  
 
2.4.1  Preparation of lysates 
 
2.4.1.1 Cell  lysates 
 
Cells were grown and stimulated as described above (2.5.1). For harvesting, cells 
were washed twice with ice-cold PBS. Last traces of PBS were removed by a pipette 
tip attached to a vacuum line. Cells were scraped off from the culture dishes using a 
rubber policeman and triton/homogenization buffer (500 µl/10 cm dish). 
Subsequently, cells were sonicated (3 x 10 sec, Banson Sonifier 450) and the 
homogenate was stored on ice for additional 60 min. To remove cellular debris, 
probes were centrifuged (15,000 x g, 10 min, 4°C) and the supernatants were stored 
at –80°C until use. Protein concentrations were determined using the Roth 
Nanoquant Protein Assay (2.4.3) 
 
Buffer 
components 
Homogenization buffer 
(1x) 
 137  mM  NaCl 
  20 mM  Tris/HCl, pH 8.0 
  5 mM  EDTA, pH 8.0 
 10%  (v/v)  Glycerol 
  1 mM  PMSF (freshly added!) 
 1  µg/ml  Leupeptin   
  1 % (v/v)  Triton X-100 (must not 
be included for 
isolation of cytoplasmic 
fractions) 
 
 
2.4.1.2  Preparation of fractionated cell lysates  
 
A 10 cm dish of confluent cells was washed twice with ice-cold PBS. Cells were 
scraped into 2 ml ice-cold PBS and concentrated (13,000 rpm, 5 min, 4°C). Cells 
were resuspended in 300 µl buffer C and incubated for 15 minutes by vigorous 
shaking at 4°C. 20 µl of 10% NP-40 were added to the homogenate, the sample was 
vortexed and centrifuged (15,000 x g, 5 min, 4°C ). The supernatant containing the 
cytosolic fraction was stored at -80°C.  
The pellet was resuspended in 100 µl buffer N and incubated for 20 minutes by 
vigorous shaking at 4°C. Finally, the lysate was centrifuged (15,000 x g, 5 min, 4°C). 
The supernatant, carrying the nuclear fraction, was collected and stored at -80°C. Materials and Methods 
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Protein concentrations were determined using the Roth Nanoquant Protein Assay 
(2.4.3). 
 
buffer 
components 
buffer C 
(1x) 
 buffer N 
(1x) 
Hepes pH 7.9  10 mM  20 mM 
KCl  10 mM       - 
NaCl      -  400mM 
EDTA 0,1  mM  0,1  mM 
EGTA 0,1  mM  0,1  mM 
NaF (freshly added)  50 mM  50 mM 
DTT (freshly added)  1 mM  1 mM 
PMSF (freshly added)  1 mM  1 mM 
Leupeptin (freshly added)  1 ng/ml  1 ng/ml 
Aprotinin (freshly added)  1 ng/ml  1 ng/ml 
Na3VO4 (freshly added)  2 mM  2 mM 
 
 
2.4.1.3 Tissue  lysates 
 
Skin samples (murine wounds) were homogenized (UltraTurrax, IKA Labortechnik) in 
4 ml of 2x triton/homogenization buffer. The tissue extract was cleared by 
centrifugation (4,000 rpm, 30 min, 4°C; Heraeus Megafuge 1.0, rotor 7570F). The 
supernatant was diluted using an equal volume of water. Protein concentrations were 
determined using the Roth Nanoquant Protein Assay (2.4.3). Aliquoted samples were 
stored at –80°C until use. 
 
 
2.4.2  Trichloroacetic acid (TCA) precipitation  
 
This method was used to concentrate proteins from a defined volume of cell culture 
supernatants for Western blot analysis. Cell culture supernatants were cleared from 
cellular contaminations using a single centrifugation step (1000 rpm, 5 min, 4°C; 
Heraeus Megafuge 1.0, rotor 7570F). Subsequently, 10% (v/v) of 70% trichloroacetic 
acid (TCA) was added to 1 ml of conditioned cell culture supernatant, mixed and 
incubated for 30 min on ice. TCA-precipitated proteins were concentrated by 
centrifugation (15,000 x g, 30 min, 4°C). The protein pellet was washed in 200 µl of 
ice-cold acetone, centrifuged for 5 min at 15,000 x g and finally resuspended in 20 µl 
of 2x Laemmli buffer. After neutralization (1 µl of 1 M Tris/HCl, pH 8.5), the samples 
were ready to use for Western blot analysis (2.4.4). 
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2.4.3  Determination of protein concentration 
 
The amount of protein in cellular and tissue lysates was determined using Roth 
Nanoquant Protein Assay (Bradford method). 5 µl of the samples diluted in 795 µl of 
distilled water were combined with 200 µl Nanoquant 5x dye solution, vortexed and 
pipetted in duplicate into appropriate wells of a 96-well ELISA plate. Different BSA 
concentrations (2.5-50 µg/ml) were used to generate a standard curve. After 10 min 
of incubation, the optical density was measured at a wavelength of 595 nm using a 
microplate reader (Bio Rad). The absorption values were calculated using the 
Microplate Manager 4.0 software (Bio Rad). 
 
 
2.4.4  Western blot analysis 
 
The Western blot technique represents a sensitive method to detect specific 
polypeptides within a complex mixture of proteins. Proteins are separated 
electrophoretically and transferred to a membrane, which is subsequently incubated 
with antibodies specific for the protein of interest. Finally, the bound antibody is 
recognized by a second anti-immunoglobulin that is coupled to horseradish 
peroxidase or alkaline phosphatase. The detection limit of this method ranges 
between 1-5 ng of an average-sized protein. 
 
Buffer 
components 
Laemmli buffer 
(4x) 
Electrophoresis 
buffer (1x) 
Transfer buffer 
(1x) 
TBST buffer 
(10x) 
Tris/HCl  125 mM (pH 6.8)  25 mM  25 mM  100 mM (pH 8.0) 
SDS 10%  (w/v)  0.1%  (w/v)  ---  --- 
Glycine ---  250  mM  192  mM  --- 
Dithiothreitol 50  mM  ---  ---  --- 
Bromophenol blue  0.01% (w/v)  ---  ---  --- 
Glycerol 30%  (v/v) ---  ---  --- 
Methanol ---  ---  20%  (v/v)  --- 
Tween 20  ---  ---  ---  5% (v/v) 
NaCl ---  ---  ---  1.5  M 
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2.4.4.1  SDS gel electrophoresis 
 
Electrophoretic separation of proteins was carried out in the discontinuous buffer 
system for SDS polyacrylamide gels as originally described by Laemmli (1970).  
50 µg of total protein were dissolved in 2x Laemmli buffer. Diluted protein samples 
were concentrated by acetone precipitation: the desired amount of protein-containing 
solution was mixed with 3 volumes ice-cold acetone and chilled at –20°C for 2 h. 
Protein was concentrated by centrifugation (15,000 x g, 15 min, 4°C). The protein-
containing pellet was suspended in 2x Laemmli buffer. After heating for 5 min at 
95°C, samples were loaded on the gel. Subsequently, the gel was run at a current of 
30 mA for a period of 1-3 hours. 
 
Resolving gel 
Component volumes (ml) per 20 ml gel 
Solution components  6% 
(> 120 kDa) 
10% 
(60-120 kDa) 
12% 
(< 60 kDa) 
H2O 10.6  7.9  6.6 
Acrylamide  mix  (30%)  4.0 6.7 8.0 
Tris/HCl (1.5 M, pH 8.8)  5.0  5.0  5.0 
SDS  (10%)  0.2 0.2 0.2 
Ammonium  persulfate  (10%)  0.2 0.2 0.2 
TEMED  0.016 0.008 0.008 
 
Stacking gel 
Component volumes (ml) per gel volume of  Solution components 
2 ml  5 ml  10 ml 
H2O  1.4 3.4 6.8 
Acrylamide mix (30%)  0.33  0.83  1.7 
Tris/HCl (1.5 M, pH 6.8)  0.25  0.63  1.25 
SDS (10%)  0.02  0.05  0.1 
Ammonium persulfate (10%)  0.02  0.05  0.1 
TEMED 0.002  0.005  0.01 
 
 
2.4.4.2  Transfer to PVDF membrane 
 
After gel electrophoresis, proteins were transferred to a polyvinylidene fluoride 
(PVDF) membrane by electroblotting (Trans-Blot SD, Bio Rad). Prior to use, the 
PVDF membrane was activated in isopropanol for 3 min and subsequently rinsed in 
deionized water. Six pieces of Whatman 3MM paper were soaked in transfer buffer 
and positioned on the anode side of the transfer apparatus. The PVDF membrane 
was placed directly on the stack of 3MM paper. The SDS gel containing the Materials and Methods 
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separated proteins was taken off the glasplates, rinsed shortly in transfer buffer, and 
placed on the top of the PVDF membrane. Finally, the gel was covered with four 
additional, transfer buffer-soaked Whatman 3MM papers. Air bubbles were squeezed 
out by a roller apparatus. The upper electrode (cathode) was positioned on the top of 
the stack and a current of 0.8 mA/cm
2 was applied. Transfer of proteins was carried 
out at room temperature and terminated after 75 min. After blotting, the membrane 
was checked by Ponceau S staining for correct electrophoretic transfer and equal 
loading. 
 
 
2.4.4.3 Immunodetection 
 
The air-dried PVDF membrane was reactivated in isopropanol and rinsed in 1x TBST 
buffer. Non-specific binding sites were blocked by shaking the membrane in a 1x 
TBST-buffered non-fat skim milk solution (5-10%) for 1 h at room temperature or 
overnight at 4°C. The membrane was subsequently exposed to antibodies (diluted 
1:500− 1:2000 in 1x TBST buffer) specific for the protein of interest. The incubation 
time varied between 1 h at room temperature, or 15 h at 4°C depending on the 
antiserum. The blot was washed three times for 15 min in 1x TBST. The primary 
antibody was detected by incubation of the membrane with a specific secondary 
antibody coupled to horseradish peroxidase (diluted 1:5000− 1:20,000 in 1x TBST) for 
45 min at room temperature. For detection of the corresponding bands, we used the 
enhanced chemiluminescence (ECL) detection kit (Amersham Pharmacia) according 
to the instructions of the manufacturer. The membrane was exposed to a film 
(Hyperfilm, Amersham Pharmacia) and developed (Hyperprocessor, Amersham 
Pharmacia). Developed films were scanned (GS 700 Imaging Densitometer, Bio 
Rad) and analyzed using the Molecular Analyst software from Bio Rad. 
 
 
2.4.5  Generation of a p68 RNA helicase antibody 
 
A synthetic peptide (H2N-FNTFRDRENYDRGY-COOH) based on the C-terminal 
sequence of the human p68 RNA helicase (GenBankTM/EBI Data Bank accession 
number NM_004396) was synthesized, coupled to keyhole limpet hemocyanin, and 
used to immunize rabbits. Notably, the peptide sequence allows immunodetection of 
both human and murine p68 RNA helicase. Materials and Methods 
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2.4.6  Enzyme-linked immunosorbent assay (ELISA) 
 
The enzyme-linked immunosorbent assay (ELISA) technique is the most sensitive 
method to specifically determine protein concentrations from different sources. 
Sensitivity is approximately 100-fold increased compared to the Western blot 
technique (2.4.4). The ELISA was performed according to the instructions of the 
manufacturer (R&D Systems, PharMingen). Briefly, microtiter plates were pre-coated 
with a monoclonal antibody specific for VEGF. Equal volumes of cell culture 
supernatant samples were pipetted into the wells of the microtiter plate and 
incubated for 2 h. Subsequently, wells were washed. An enzyme-linked polyclonal 
antibody specific for VEGF was added for 2 hours, and wells were subsequently 
washed for three times. Wells were then incubated with substrate solution. The color 
reaction develops in direct proportion to the amount of bound antigen. The optical 
densities were calculated using the Microplate Manager 4.0 software from Bio Rad. 
 
 
2.4.7 Immunohistochemistry 
 
2.4.7.1  Preparation of frozen tissue sections 
 
Wounds were excised as described in section 2.7.1. They were fixed on a 
membrane, bisected and frozen in tissue freezing medium (Leica Instruments) at 
-80°C. 6 µm frozen sections were generated on a cryostat (CM 3050S, Leica 
Instruments) and adhered to glass slides (Roth). The sections were fixed in acetone 
for 1 min, air-dried and stored at –80°C. 
 
 
2.4.7.2 Immunoperoxidase  staining 
 
Immunodetection of proteins in frozen tissue sections was performed using the ABC 
staining systems from Santa Cruz. After thawing the slides to room temperature, 
tissue sections were treated as indicated in the flow chart. Blocking reaction and 
antibody incubation were performed in a humidified chamber. 
 
tissue section 
▼ 
acetone  
(10 min) 
▼ Materials and Methods 
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PBS  
(3 x 5 min) 
▼ 
hydrogen peroxide 
(1% in PBS, 10 min) 
▼ 
PBS 
(2 x 5 min) 
▼ 
blocking serum  
(1.5% in PBS, 60 min) 
▼ 
1. antibody  
(0.1-20 µg/ml in blocking serum, 1-20 h) 
▼ 
PBS  
(3 x 5 min) 
▼ 
2. antibody 
(45 min) 
▼ 
PBS  
(3 x 5 min) 
▼ 
avidin/biotin complex 
(30 min) 
▼ 
PBS  
(3 x 5 min) 
▼ 
peroxidase substrate 
 
 
 
2.4.7.3 Hematoxylin  staining 
 
To visualize nuclei in tissue specimens, the sections were counterstained with 
hematoxylin solution as shown in the flow chart: 
 
tissue section 
▼ 
hematoxylin solution 
(1-10 min) 
▼ 
Aquadest 
(3 x 30 sec) 
▼ 
Scott water 
(30 sec) 
▼ 
Aquadest 
▼ 
slides mounted 
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2.5  Cell culture  
 
All cell lines were cultured at 37°C in a humidified atmosphere containing 5% CO2 
(Heraeus BBD 6220 incubator). For subcultivation, cells were washed once in 
phosphate buffered saline (PBS), subsequently trypsinized (Trypsin, EDTA) and 
diluted in a appropriate ratio (1:12 for HaCaT cells, 1:10 for HEK 293 cells). For long-
term storage, the cells were treated as follows: after trypsinization, cells were 
pelleted (5 min at 1100 rpm, Heraeus Megafuge 1.0, rotor 75750F), diluted in 
freezing medium (growth medium with 20% FCS supplemented with 10% DMSO) 
and stored in cryotubes (Nunc). The cryotubes were cooled down slowly and finally 
stored in liquid nitrogen. 
 
 
2.5.1  Culture and stimulation of HaCaT cells 
 
The human keratinocyte cell line HaCaT (Boukamp et al. 1988) was grown in DMEM 
supplemented with 10% FCS and the antibiotics penicillin (100 U/ml)/streptomycin 
(100 µg/ml). Under these culture conditions the cells remain undifferentiated. For the 
induction experiments, cells were grown to confluence without changing the medium 
and rendered quiescent by 24 h incubation in serum-free DMEM. Cells were then 
incubated for varying periods on fresh DMEM containing the factors or reagents of 
interest. 
 
 
2.5.2  Culture of HEK 293 cells 
 
Human embryonic kidney cells (HEK) were grown in DMEM supplemented with 10% 
FCS and the antibiotics penicillin (100 U/ml) and streptomycin (100 µg/ml). 
 
 
2.5.3 Transfection   
 
For transfection experiments 2x10
5 cells/6 cm dish were plated and grown for 24 h to 
reach 50-80% confluence. The DNA of interest (5 µg) and lipofectamine (10 µl) were 
diluted into 250 µl of unsupplemented DMEM, combined and mixed gently. The 
solutions were allowed to form DNA-liposome complexes for 15 min at room 
temperature. Full medium covering the target cells was replaced with 1,5 ml serum- Materials and Methods 
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and antibiotic-free DMEM. The diluted DNA-liposome complex was added and cells 
were incubated for 3 hours. Subsequently, 2ml medium containing 20% serum was 
added. 24 hours after transfection, medium was replaced for full medium. For stable 
transfection 1000 µg/ml geneticin (Gibco Life Technologies) was added two days 
after transfection. The transfected cells were selected for a period of 6 weeks in the 
presence of geneticin. Surviving clones were isolated, subcultured and tested for p68 
RNA helicase expression by western blotting. 
 
 
2.6  In vitro transcription/translation 
 
We performed an in vitro transcription/translation experiment to control the specificity 
of the p68 antibody. The TNT
RCoupled Reticulocyte System was used as described 
by the manufacturer. The following reaction components were added into a 1,5 ml 
microcentrifuge tube:  
 
 
component 
radioactive 
reaction 
 
non-
radioactive 
reaction 
TNT
RRabbit Reticulocyte Lysate  12,5 µl  12,5 µl 
TNT
RReaction buffer  1,0 µl  1,0 µl 
T3 RNA polymerase  1,0 µl  1,0 µl 
Amino acid mixture, minus Leucine, 1mM      -  0,5 µl 
Amino acid mixture, minus Methionine, 1mM  0,5 µl      0,5 µl 
[
[35S]methionine  1,0 µl     - 
RNasin 0,5  µl  0,5  µl 
Template (pcDNA-p68) [1µg/µl]  1 µl  1 µl 
H2O  7 µl  7 µl 
 
After an incubation for 90 minutes at 30°C, 2,5 µl and 5 µl aliquots from each reaction 
were removed and SDS-PAGE was performed. The gel carrying the non radioactive 
in vitro translation products was analyzed by Western blot using p68 specific 
antibody. The gel carrying the [
35S]methionine labeled samples was fixed in 25% 
isopropyl alcohol v/v, 10% acidic acid v/v, dried and exposed on a Phosphoimager 
plate for analysis. 
 
 Materials and Methods 
 
  43
2.7 Proliferation 
 
0.5 x 10
5 cells (HaCaT keratinocytes or cell lines) per well were seeded into 24-well 
plates. After reaching 50-80% confluence cells were transfected with siRNA specific 
for p68. Transfected cells or cell lines were starved for 24 hours with serum-free 
DMEM. Proliferation of cells was assessed using 1 µCi/ml
 of [
3H]-methyl-thymidine in 
the presence or absence of serum for 24 hours. After 24 h, cells were washed twice 
with PBS, incubated in
 5% trichloroacetic acid (TCA) at 4°C for 30 min, and the DNA 
was solubilized in 0.5 M NaOH for 30 min at 37°C. Finally, [
3H]-thymidine 
incorporation was determined. 
 
 
2.8 Confocal  microscopy 
 
Confocal microscopy was performed using the Zeiss LSM 510 META microscope 
(Carl Zeiss, München, Germany) equipped with a 405nm laser for DAPI/ blue 
(emission at 458nm), a 488nm laser for GFP/ green (emission at 520nm) and a 
543nm laser for CY3/ red (emission at 633nm). To assess expression of p68-GFP 
fusion protein, transfected cells were fixed (0.2% (w/v) EDTA in methanol) at -20 °C 
for at least 1 h. For indirect immunofluorescence, cells were incubated with bovine 
serum albumin (1 mg/ml in PBS) for 1 h to block nonspecific binding sites. Incubation 
with the nucleolin-specific antibody (1:100 in PBS/BSA) was done at 4°C overnight. 
After a final wash with PBS/BSA, the FluoroLink
TM Cy
TM3 labelled goat anti-mouse 
IgG (1:2000) (Amersham Pharmacia, Freiburg, Germany) was added for 1 h and 
DNA was stained with 4,6-diamino-2-phenylinole (1:1000, 5 min) (Sigma Aldrich Fine 
Chemicals, Deisenhofen, Germany). Preparations were mounted with ProLong 
Antifade kit (Molecular Probes, Germany). 
 
 
2.9  Silencing p68 RNA helicase gene expression by 
siRNA 
 
Short interfering RNA species (siRNAs) can be used to silence gene expression in a 
sequence-specific manner (Fire et al., 1998). Synthetic siRNAs are characterized by Materials and Methods 
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5`phosphorylated ends, a 19-nucleotide (nt) duplexed region and 2-nt unpaired and 
unphosphorylated 3`ends. After siRNAs have entered the cell via transfection, they 
are incorporated into a multiprotein RNA-induced silencing complex (RISC). The 
siRNA-protein complex targets endogenous mRNA whose sequence matches that of 
the siRNA. Finally, the target mRNA is cleaved at a single site by the RISC 
endonuclease activity (Elbashir et al, 2001). 
p68-specific siRNA was generated by Qiagen-Xeragon (Hilden, Germany) using 
AACCGCAACCATTGACGCCAT (nt 152-172; Acc.No. NM_004396) as the cDNA 
target sequence. The delivered siRNA duplex sequence was formed by the sense 5`-
CCGCAACCAUUGACGCCAUdTdT-3` and antisense 5`-AUGGCGUCAAUGGUUG 
CGGdTdT-3` oligonucleotides. As a control, a non-silencing siRNA duplex with 
symmetric 2-nt 3`overhangs of the cDNA target sequence 5`-
AATTCTCCGAACGTGTCACGT-3` was used. This sequence only matched with a 
sequence derived from Thermotoga maritime. The sense oligonucleotide was 
coupled to Rhodamine to assess transfection efficiencies. Transfection of cells 
(HaCaT, HEK) was performed as described above (2.5.3). 
 
 
2.10  Wound healing studies 
  
Female C57BLKS mice were obtained from Charles River (Sulzfeld, Germany). 
Female C57BLKS-iNOS
-/- mice were a generous gift of G. Geisslinger, Frankfurt. 
Mice were maintained under a 12h light/12h dark cycle at 22°C until they were 8 
weeks of age. At this time they were caged individually, monitored for body weight 
and wounded as described below. 
 
 
2.10.1 Wounding of mice 
 
Mice were anesthetized with a single i.p. injection of ketamine (80 mg/kg body 
weight)/xylazine (10 mg/kg body weight). The hair on the back of each mouse was 
cut, and the back was subsequently wiped with 70% ethanol. Six full-thickness 
wounds (5 mm in diameter, 3-4 mm apart) were made on the back of each mouse by 
excising the skin and the underlying panniculus carnosus. The wounds were allowed 
to form a scab. Skin biopsy specimens were obtained from the animals 1, 3, 5, 7 and 
13 days after injury. At each time point, an area which included the scab and the Materials and Methods 
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complete epithelial margin was excised from each individual wound. As a control, a 
similar amount of skin was taken from the backs of nonwounded mice. For each 
experimental time point, tissue from four wounds each from four animals (n=16 
wounds, RNA analysis) and from two wounds each from four animals (n=8 wounds, 
protein analysis) were combined and used for RNA and protein preparation. Non-
wounded back skin from four animals served as a control. All animal experiments 
were carried out according to the guidelines and with the permission from the local 
government of Hessen (Germany). 
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3 
Results 
___________________________________ 
 
3.1  Identification of p68 as a novel NO-regulated gene in 
keratinocytes 
 
3.1.1  Identification of novel NO-regulated genes by a differential 
cDNA library from GSNO-stimulated HaCaT keratinocytes 
 
It is now well established that the short-lived radical NO pivotally drives epithelial 
movements and gene expression during skin repair (Frank et al., 2002). To gain a 
deeper insight into NO actions on keratinocyte behavior, a differential cDNA library 
from NO-stimulated HaCaT keratinocytes was established. For this purpose, HaCaT 
cells were grown to confluence, starved and subsequently stimulated with 500 µM 
GSNO. RNA was isolated and used as starting material for the synthesis of   
 
   a  b 
Figure 3.1 Identification of novel NO-regulated genes by a differential cDNA library from GSNO-stimulated HaCaT 
keratinocytes. a, bacterial colonies from a NO-induced differential HaCaT keratinocyte cDNA library were spotted in 
duplicate onto nylon membranes and screened for regulated sequences by hybridization using [α -
32P]-radiolabeled cDNAs 
from non-stimulated control (ctrl) and GSNO-treated HaCaT cells (GSNO) as indicated. The initially identified p68 cDNA 
clone is indicated by arrows. b, keratinocytes were rendered quiescent and subsequently stimulated with 500 µM GSNO 
for the indicated time periods. Induction of mRNA expression in the cells was assessed by RNase protection assay. 1000 
counts of the hybridization probes as used as a size marker. tRNA was used as a negative control. Representative 
experiments are shown. 
ctrl
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subtractive complementary DNA (cDNA). Screening of duplicate filters with 
radioactive-labeled cDNAs from GSNO- and non-treated HaCaT cells identified 
different bacterial clones which carried cDNA-fragments from potentially NO-inducible 
transcripts. Among these clones a 270 bp cDNA fragment with a 100% nucleotide 
homology to human p68 DEAD box RNA helicase (p68, Gen Bank Accesion Number 
NM_004396) was found (Figure 3.1a). After propagation of the identified clones, the 
plasmids were isolated and subsequently analyzed by sequence analysis. To confirm 
the NO-inducibility of the identified clones, RNase protection assays were performed 
using RNA from GSNO-stimulated HaCaT keratinocytes (Figure 3.1b, see also 
3.1.2). 
 
 
3.1.2  NO induces p68 mRNA expression 
 
As a next step, we had to confirm the potency of NO to induce p68 mRNA expression 
in keratinocytes in vitro. To this end, we stimulated quiescent HaCaT keratinocytes 
using GSNO as NO-donating substance. Indeed, we could detect a marked and 
dose-dependent induction of p68 mRNA expression in the cells (Figure 3.2a, b) 
 
 
a b 
Figure 3.2 NO induces p68 mRNA expression. a, keratinocytes were rendered quiescent and subsequently stimulated 
with 500 µM GSNO for the indicated time periods. Induction of p68 mRNA expression in the cells was assessed by RNase 
protection assay. 1000 counts of the hybridization probe was used as a size marker. tRNA was used as a negative control. 
One representative experiment is shown. b, quantification of GSNO-induced p68 mRNA (x-fold induction, 5 h after 
stimulation). **, P < 0.01; *, P < 0.05 (Student's t test) as compared to control. Bars indicate the mean ±SD obtained from 
four (n=4) independent cell culture experiments. 
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3.1.3  NO regulates p68 expression at the transcriptional level 
 
Next, we determined whether NO might act by transcriptional activation of the p68 
gene. Additionally gene activation might be dependent from de novo protein 
synthesis. Thus, we added 2 µg/ml actinomycin D (inhibitor of transcription) or 25 
µg/ml cycloheximide (inhibitor of protein synthesis) to quiescent HaCaT keratinocytes 
45 min prior to GSNO treatment (Figure 3.3). We determined a GSNO-mediated 
increase in p68 mRNA levels, that could be blocked in the presence of actinomycin D 
(Figure 3.3, as indicated) while cycloheximide did not suppress GSNO-induced p68 
mRNA expression (Figure 3.3, as indicated). These findings suggest that GSNO-
triggered p68 gene activation is independent from de novo protein synthesis, but 
resembles characteristics common to activation primary of response genes. 
 
 
Figure 3.3 NO regulates p68 expression at the transcriptional level. RNase protection assay demonstrating the 
inducion of p68 mRNA expression by the NO-donating agent GSNO. Cells were rendered quiescent by serum starvation 
and stimulated with 500 µM GSNO in the presence or absence of 2 µg/ml actinomycin D (ActD) or 25 µg/ml cycloheximide 
(CHX) for the indicated time periods. 20 µg of total cellular RNA were analysed p68 mRNA expression. 1000 cpm of the 
hybridization probe were used as a size marker. tRNA was used as a negative control. One representative experiment is 
shown The GSNO-induced increase in p68 mRNA levels was assessed by PhosphoImager (Fuji). 
 
 
3.1.4  NO regulates p68 protein expression 
 
To date, we had to face the situation that no anti p68 specific antibody was 
commercially available. In order to investigate p68 protein expression, we decided to 
generate a p68 specific antibody. For this purpose, rabbits were immunized with a 
synthetic peptide (H2N-FNTFRDRENYDRGY-COOH) based on the C-terminal 
sequence of the human p68 RNA helicase (GenBankTM/EBI Data Bank accession 
number NM_004396). 
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3.1.4.1  Characterization of the p68 specific antibody 
 
As a crucial step, we had to confirm specificity of our anti-p68 antiserum, which had 
been raised in rabbits as described above. For this reason, we cloned the cDNA of 
the p68 open reading frame (ORF) into the eukaryotic expression vector 
pcDNA3.1(+) (Figure 3.4a). First, we performed an in vitro transcription/translation 
assay in the presence of [
35S]-methionine. Exposure of the corresponding 
radiolabeled gel revealed the presence of two major bands, from which one clearly 
represented the expected 68 kDa protein. Moreover, as we transferred the 
transcription/translation reaction to a PVDF membrane for immunoassay, we could 
clearly demonstrate the specificity of the p68 antibody which detects a 68 kDa protein 
 
p68 RNA helicase ORF
HindIII BamHI
1µg 3µg 1µg 3µg
35S-methionine immunoblot
66 kDa 66 kDa
HEK-p68
pcDNA3.1 pcDNA3.1-
p68ORF
 ctrl
66 kDa
66 kDa
p68 p68 p68 p68
ab
cd
 
Figure 3.4 Specificity of the anti-p68 antiserum. A polyclonal antiserum against p68 protein was raised in rabbits. a, to 
verify the specificity of the antiserum, the full-length p68 cDNA was cloned into pcDNA3.1(+). b, SDS-gel electrophoresis of 
the in vitro-transcription/translation reaction of p68 cDNA using the pcDNA3.1(+) construct and [
35S]-methionine (left panel). 
The immunoblot of the in vitro transcription/translation reaction is shown in the right panel. c, immunoblot for the presence of 
p68 protein in pcDNA3.1(+)- (ctrl) and pcDNA3.1(+)-p68- (p68) transfected HEK cells. d, immunoblot for the presence of 
p68 in stably transfected HaCaT control (vector #1-3) and stable p68-overexpressing (p68 #1-2) cell lines. Transiently 
transfected HEK cells (HEK-p68) were used as a control. Results 
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and also the second band, which is most likely to represent an incomplete translation 
product (Figure 3.4b). Additionally, we detected strongly increased levels of p68 in 
pcDNA3.1-p68-ORF transiently transfected human embryonal kidney (HEK) cells 
(Figure 3.4c) and stably transfected HaCaT keratinocyte cell lines (Figure 3.4d). 
 
 
3.1.4.2  NO induces p68 protein expression  
 
As a next step, we had to confirm the potency of NO to induce p68 protein 
expression in keratinocytes. For this purpose, we stimulated quiescent HaCaT 
keratinocytes using different NO-donating substances. p68 protein induction was 
determined using the verified p68 specific antibody. 
 
 
Figure 3.5 NO induces p68 protein expression. Immunoblots demonstrating the stimulation of p68 protein expression in 
quiescent HaCaT cells by the NO-donors GSNO (upper panel) and Sp-NO (lower panel). p68-transfected HEK cells 
(HEK-p68) were used to control the specificity of the anti-p68 antiserum. 
 
 
As shown in Figure 3.5, low basal levels of p68 protein expression were detected in 
quiescent keratinocytes (ctrl) whereas a strong increase in p68 protein expression 
was observed upon NO treatment. More important, induction of p68 expression was 
not restricted to GSNO alone, as additional the NO-donating agent Sp-NO (Figure 
3.5, lower panel) mediated comparable effects on p68 expression. 
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3.1.5  Potential involvement of cGMP or MAPK pathways in p68 
induction 
 
To gain more insight into the signaling pathway by which NO induces the observed 
p68 mRNA and protein up-regulation, we investigated possible signaling pathways 
which might be involved. 
 
3.1.5.1  NO mediated p68 expression is not dependent on activation of soluble 
guanylyl cyclase 
 
NO is able to activate the soluble guanylyl cyclase (sGC) (Garthwaite et al., 1988; 
Schmidt and Walter, 1994) and thereby leads to an increase in the intracellular levels 
of cGMP which is the second messenger for most of the physiological actions of NO. 
To examine whether the NO-induced p68 expression is secondary to activation of 
soluble guanylyl cyclase and hence cGMP, we treated HaCaT keratinocytes with the 
membrane-permeable cGMP analogue 8-bromo-cGMP (500 µM). As shown in 
Figure 3.6a, the cGMP treatment did not alter p68 protein expression levels. 
 
  a 
  b 
Figure 3.6 NO-induced p68 protein expression is not mediated by activation of soluble ganylyl cyclase. Serum-
starved HaCaT keratinocytes were stimulated with (a) 500 µM cGMP or 500 µM GSNO for 16 hours. b, starved cells were 
stimulated with activator and inhibitors of sGC 30 min before 500 µM GSNO were added. After 16 hours lysates (50 µg) 
were analyzed by immunoblot.  
 
Furthermore, we tested the two guanylate cyclase inhibitors NS 2028 (100nM) and 
ODQ (200µM), which were added to the cells 30 min prior to GSNO treatment. 
Additionally, the sGC stimulator YC-1 (10µM) was tested in the presence or absence 
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of GSNO. Figure 3.6b shows that neither the inhibitors nor the stimulator of sGS 
activity had any influence on NO-mediated p68 expression. These results indicate 
that NO-mediated induction of p68 expression is most likely independent of the 
intracellular formation of cGMP. 
 
 
3.1.5.2  MAPK cascade is not involved in NO-induced p68 expression 
 
It was shown that NO is able to activate mitogen-activated protein kinase (MAPK) 
cascades in different cell types (Lander et al., 1996; Pfeilschifter and Huwiler, 1996; 
Callsen et al., 1998). Therefore, we decided to investigate the potential involvement 
of MAPK cascades in NO-induced p68 protein expression. To this end, starved 
HaCaT keratinocytes were treated with different cell-permeable MAPK cascade 
inhibitors prior to the addition of GSNO. Neither the JNK inhibitor II which is a 
selective and reversible inhibitor of c-Jun N-terminal kinase (JNK) nor U0126 which is 
a specific inhibitor of MEK1 and MEK2, nor the highly specific inhibitor of p38 kinase 
were able to alter p68 protein expression. 
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protein
66 kDa
 
Figure 3.7 MAPK cascade is not involved in NO-induced p68 expression. Starved HaCaT keratinocytes were 
stimulated with GSNO (500 µM) in the presence or absence of JNK Inhibitor II (1 µM), U0126 (1 µM) or SB 203580 (10 
µM). Lysates (50 µg) were analyzed by immonoblot for the presence of p68 protein.  
 
 
3.2  Growth factors, serum and cytokines induce p68 
expression 
 
3.2.1  Growth factors and serum stimulate p68 expression 
 
As we are especially interested in keratinocyte movements in the context of skin 
repair, we now investigated the potency of those mediators to regulate p68 
expression that are well established to drive keratinocyte actions during healing in 
vivo (Martin, 1997; Werner and Grose, 2003). Notably, the potent keratinocyte 
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Figure 3.8 Growth factors and serum stimulate p68 expression in keratinocytes. HaCaT keratinocytes were starved 
for 24 and subsequently stimulated with 10 ng/ml EGF (a), 10 ng/ml TGF-α (b), 10% FCS (c), or 10 ng/ml KGF (d) for the 
indicated time periods. Induction of p68 mRNA expression in the cells was assessed by RNase protection assay. 1000 
counts of the hybridization probe was used as a size marker (upper panels). A quantification of p68 mRNA (x-fold 
induction) is shown in the middle panels. **, P < 0.01; *, P < 0.05 (ANOVA, Dunnett’s method) as compared to control. 
Bars indicate the mean ±SD obtained from four (n=4) independent cell culture experiments. Immunoblots demonstrating 
growth factor and serum stimulation of p68 protein expression in HaCaT cells are shown in the lower panels. p68-
transfected HEK cells (HEK-p68) were used to control the specificity of the anti-p68 antiserum. Results 
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mitogens EGF (Figure 3.8a), TGF-α  (Figure 3.8b), serum (Figure 3.8c) and also 
KGF (Figure 3.8d) were potent inducers of p68 expression in cultured HaCaT cells. 
Interestingly, the increase in p68 protein expression was long-lasting for all growth 
factors tested, as we found still elevated p68 levels after 48h of stimulation (Figures 
3.8a-d). 
 
3.2.2  Pro-inflammatory cytokines induce p68 expression 
 
Inflammation, reepithelialisation, and granulation tissue formation are driven in part 
by a complex mixture of growth factors and cytokines, which are released into the 
area of injury (Clark, 1996). Especially, pro-inflammatory cytokines are important 
mediators of cellular actions during tissue regeneration.  
We could show that also a mixture of pro-inflammatory cytokines clearly induced p68 
expression in HaCaT keratinocytes (Figure 3.9), although p68 protein levels declined 
earlier when compared to growth factor-stimulated cells.  
 
Figure 3.9 Pro-inflammatory cytokines induce p68 expession in keratinocytes. Starved HaCaT keratinocytes were 
stimulated with a combination of IL-1β  (2 nM), TNF−α  (2 nM) and IFN-γ  (100U/ml) for the indicated time periods. a, 
induction of p68 mRNA expression in the cells was assessed by RNase protection assay. 1000 counts of the hybridization 
probe was used as a size marker. b, a quantification of p68 mRNA (x-fold induction). **, P < 0.01; *, P < 0.05 (ANOVA, 
Dunnett’s method) as compared to control. Bars indicate the mean ±SD obtained from four (n=4) independent cell culture 
experiments. c, an immunoblot demonstrating cytokine stimulation of p68 protein expression in HaCaT cells. 
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It is known that a mixture of cytokines also induces iNOS expression in keratinocytes 
(Frank et al., 1998, 2000). To determine a possible role of endogenously produced 
NO in p68 expression, we treated cells with cytokines (IL-1β , TNF-α , IFN-γ ) in the 
presence or absence of the NOS inhibitor N
G-monomethyl-L-arginine (L-NMMA). 
However, and most probably due to the delayed appearance of iNOS in the cells 
after 12 h (Frank et al., 1998, 2000), we could not detect an influence of endogenous 
NO on p68 expression (Figure 3.10).  
 
p68
protein
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cytmix
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cytmix + L-NMMA
cytmix + L-NMMA
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66 kDa
 
Figure 3.10 p68 expression is not induced by endogenously produced NO. HaCaT keratinocytes were rendered 
quiescent by serum starvation and subsequently treated with a combination of inflammatory cytokines (2 nM of IL-1β,  2 
nM TNF−α , 100 U/ml IFN-γ ) in the presence or absence of 2 mM L-NMMA for the indicated time periods. Induction of p68 
protein expression in the cells was assessed by immonoblot. 
 
In summary, we could determine a series of wound healing associated mediators, in 
addition to exogenous NO, as potent inducers of p68 expression in keratinocytes. 
 
 
3.3  p68 is localized in the nucleus 
 
3.3.1  p68 is localized in nuclei of human and murine keratinocytes 
in vitro 
 
p68 has been described to localize in the nuclei of interphase cells in vitro (Lamm et 
al., 1996; Nicol et al., 2000). To determine if this is also true for keratinocytes, we 
separated lysates of human HaCaT and murine PAM 212 keratinocytes into cytosolic 
and nuclear fractions. As shown in Figure 3.11 p68 protein was predominantly 
localized in the nuclear compartment in human and murine keratinocytes. 
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Figure 3.11 p68 is localized in nuclei of human and murine keratinocytes in vitro. Lysates of exponentially growing 
human HaCaT and murine PAM 212 keratinocytes were separated into cytosolic and nuclear fractions and subsequently 
analyzed by immunoblot for the presence of p68 protein as indicated 
 
3.3.2  Construction of a p68/ GFP fusion protein 
 
As a next step, we intended to further characterize the subcellular localization of p68, 
as we had found the protein predominantly localized in the nuclei of keratinocytes. To 
this end, we first constructed a p68/GFP fusion protein by cloning the human p68 
ORF without stop codon into the pEGFP-N1 vector (Figure 3.12).  
 
 
 
Figure 3.12  Map of the pEGFP-N1-p68 construct 
 
The pEGFP-N1-p68 construct was transiently transfected into HaCaT keratinocytes. 
Again, we could confirm the presence of the transfected p68/GFP fusion protein in 
nuclear preparations of the cells using a GFP-specific antibody (Figure 3.13a). 
Furthermore, fluorescent microscopy revealed the nuclear staining of the p68/GFP 
Nhe I Hind III
p68 RNA-helicase ORF without stop codonResults 
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fusion protein. Interestingly, the nuclear staining showed dense nuclear 
accumulations (Figure 3.13b). 
 
a 
b 
                p68/GFP fusion protein                           GFP alone 
 
Figure 3.13 p68 localizes in keratinocyte nuclei. Localization of the p68/GFP fusion protein in nuclei of transiently 
transfected HaCaT cells. a, lysates of pEGFP-N1-p68-transfected or vector-transfected keratinocytes were separated into 
cytosolic and nuclear fractions and subsequently analyzed by immunoblot for the presence of p68/GFP fusion protein 
(anti-GFP-antibody). b, localization of p68/GFP fusion protein (left panel) or GFP alone (right panel) as assessed by 
fluorescent microscopy. 
 
3.3.3  p68 localizes in nucleoli of keratinocytes 
 
It is known from the literature that during late telophase p68 was found to co-localize 
with the nucleolar protein fibrillarin in nascent nucleoli (Nicol et al., 2000). Therefore, 
we speculated whether nuclear accumulations of p68/GFP fusion protein of 
transfected keratinocytes (Figure 3.13b) are localized into nucleoli. To address this 
question, we transiently transfected HaCaT keratinocytes with the pEGFP-N1-p68 
construct. Nucleolin was chosen to specifically identify nucleoli. Nucleolin represents 
cytoplasm
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nuclei
nuclei
p68-GFP
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a nonhistone nucleolar protein of eucaryotic cells that is present in abundance at the 
dense fibrillar and granular regions of the nucleolus (Bugler et al., 1982; Shaw and 
Jordan, 1995). Confocal microscopy revealed a strong co-localization of p68/GFP  
 
  a 
b 
Figure 3.14 p68 localizes to nucleoli in keratinocytes. a, co-localization of nucleolin and the p68/GFP fusion protein in 
nuclei of transiently transfected HaCaT cells. Lysates of p68-transfected keratinocytes were separated into cytosolic and 
nuclear fractions and subsequently analyzed by immunoblot for the presence of nucleolin (anti-nucleolin) and p68-GFP 
fusion protein (anti-GFP) as indicated. b, co-localization of p68/GFP fusion protein and nucleolin as assessed by confocal 
microscopy. 
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with nucleolin in transfected keratinocytes, and both proteins matched completely in 
their spatial expression pattern (Figure 3.13b). The observed localization strongly 
suggested the presence of p68 within the nucleoli of the cells, as nucleolin is 
established to be present in the fibrillar and granular regions this distinct nuclear sub-
compartment (Bugler et al., 1982; Shaw and Jordan, 1995; Srivastava and Pollard, 
1999). 
 
 
3.4  p68 and skin repair 
 
3.4.1.  p68 protein expression is transiently decreased in wounded 
skin 
 
Next, we investigated the presence of p68 mRNA and protein expression in normal 
and wounded murine skin. Moreover, as we had isolated p68 as a NO-inducible gene 
in keratinocytes, we also analyzed iNOS-deficient (iNOS
-/-) mice for p68 expression. 
We found a constitutive expression of p68 in non-wounded skin in both wild-type and 
iNOS-deficient animals (Figure 3.15a, b;  ctrl skin). However, wounding led to an 
unexpected expression pattern of p68 in wild-type and iNOS knock-out animals. 
Whereas p68 mRNA levels were not significantly altered in healthy animals, we 
detected a doubling of p68 mRNA expression in wounds from NO-deficient mice 
which turned out to be significant (Figure 3.15b). However, in both experimental 
setups, p68 protein expression diminished rapidly after wounding in the presence of 
p68 mRNA (Figure 3.15c). Interestingly, p68 protein reappeared at the end of the 
inflammatory phase of repair in control mice (Figure 3.15c,  upper panel). 
Unexpectedly, as we had described p68 to be under a positive regulatory control of 
exogenously added NO in keratinocytes in vitro, we found a marked re-increase of 
p68 after injury in NO-deficient mice that paralleled the increase in p68 mRNA in 
these animals. Notably, p68 was clearly detectable after 3 and 5 days of repair in 
iNOS knock-out mice, at time points when p68 was not yet present in those amounts 
that could be detected by immunoblotting (Figure 3.15c). 
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Figure 3.15 Expression of p68 upon skin wounding. a, regulation of p68 mRNA expression in C57BLKS (wild-type) 
and C57BLKS-iNOS
-/- (iNOS
-/-) mice was assessed by RNase protection assay. 1000 counts of the hybridization probe 
was used as a size marker. b, a quantification of p68 mRNA (x-fold induction) is shown. **, P < 0.01; *, P < 0.05 (ANOVA, 
Dunnett's method) as compared to control skin. Bars indicate the mean ±SD obtained from wounds (n=48) isolated from 
animals (n=12) from three independent animal experiments. c, total protein (100 µg) from lysates of non-wounded and 
wounded back skin (day 1, 3, 5, 7, and 13 after injury as indicated) isolated from C57BLKS (wt) and C57BLKS-iNOS
-/- 
(iNOS
-/-) mice as indicated were analyzed by immunoblot for the presence of p68 protein. Eight wounds (n=8) from the 
backs of four animals were excised for every experimental time point and used for protein isolation. Ctrl skin refers to 
nonwounded skin. p68 protein is indicated by an arrow. 
 
 
3.4.2  p68 protein is restrictively localized in nuclei of keratinocytes 
in vivo 
 
As a next step, we determined the localization of p68 protein at the wound site. We 
did so, as an absent immunopositive signal for p68 protein in Western blot analysis 
does not necessarily mean the total absence of the protein at the wound site. Thus, 
we analyzed 5 day wounds of C57BLKS control mice by immunohistochemistry. It is 
important to note that we indeed detected immunopositive signals for p68 protein at 
the wound site. Interestingly, p68 expression was clearly restricted to keratinocyte 
nuclei of non-wounded skin (Figure 3.16a) and of the developing epithelium (Figure 
3.16b).  
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a 
b 
c 
Figure 3.16 p68 is localized in keratinocytes in vivo. frozen sections (6µm) from nonwounded mouse skin (a) and 
mouse wounds at day 5 post-wounding (b) were incubated with the polyclonal antiserum directed against p68. All sections 
were stained with the avidin-biotin-peroxidase complex system using 3,3-diaminobenzidine-tetrahydrochloride as a 
chromogenic substrate. Immunopositive signals in nuclei of the developing epithelium are indicated with arrows. As 
immunopositive signals localized in nuclei, we did not counterstain nuclei with hematoxylin. d, dermis; e, epithelium; g, 
granulation tissue. c, lysates of non-wounded and wounded back skin (day 5 and 7 after injury as indicated) isolated from 
C57BLKS mice were separated into cytosolic and nuclear fractions by differential centrifugation. Cytosolic and nuclear 
fractions were subsequently analyzed by immunoblot for the presence of p68 protein as indicated. Eight wounds (n=8) 
from the backs of four animals were excised for every experimental time point and used for protein isolation. p68 protein is 
indicated by an arrow. 
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Moreover, our p68 antibody recognizes only about one third of the epithelial nuclei, 
suggesting that the nuclear presence of p68 might be associated with a distinct 
phase of the cell cycle (Figure 3.16a, arrows). Additionally, it is important to note that 
the particularly weak p68-specific staining of the nuclei could only be detected when 
nuclei were not counterstained with hematoxylin (Figure 3.16a). Evidently, the weak 
immunopositive signals in wound sections confirmed the low levels of p68 protein 
observed by immunoblotting, as the protein indeed was present, but clearly 
detectable, only in small amounts at the wound site. However, histological data 
suggested that we might succeed to detect p68 protein at early states of healing by 
immunoblot, when we enrich the wound lysates for nuclei. As shown in Figure 3.16b, 
we now detected clearly visible amounts of p68 protein in the nuclear fractions of 5 
and 7 day wound tissue, strongly confirming our immunohistological findings.  
Interestingly, p68 mRNA was present in epidermal keratinocytes (wound margin) and 
mesenchymal cells of the dermis (inner wound) (Figure 3.17a). However, only 
keratinocytes expressed p68 protein (Figure 3.17b). 
 
 
a            b  
 
Figure 3.17 Distribution of p68 expression in 1 d wounds. a, RNase protection assay demonstrating distribution of p68 
mRNA from C57BLKS (wt) at the wound margin and inner region of wound. 1000 counts of the hybridization probe was 
used as a size marker. b, total protein (100 µg) from lysates of the wound margin and inner region of wound isolated from 
C57BLKS (wt). p68 protein is indicated by an arrow. 
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3.5  Silencing p68 RNA helicase protein expression by 
short interfering RNA (siRNA) 
 
To gain more information about p68 protein function, we specifically down-regulate 
p68 gene expression by short interfering RNA (siRNA). The siRNA technique uses 
molecules that bind the target messenger RNA in a sequence-specific manner and 
subsequently catalyze the endonucleolytic cleavage of this mRNA (Fire et al., 1998; 
Elbashir et al., 2001). In order to investigate p68 protein function HaCat keratinocytes 
were transfected with p68-specific siRNA. Figure 3.18 shows the down-regulation of 
endogenous, FCS induced p68 using p68-specific siRNA molecules. 
 
 
Figure 3.18 Silencing p68 gene expression by siRNA. HaCaT keratinocytes were transfected with p68-specific siRNA 
(p68si) or scrambled oligos and grown in the presence of 10% FCS for the indicated time periods. Lysates (50 µl) were 
analyzed by immunoblot. 
 
 
3.6   p68 expression is functionally connected to 
keratinocyte proliferation and VEGF gene expression 
 
Finally, we determined whether p68 expression was implicated in the control of those 
important keratinocyte functions that also participate in skin repair. Thus, we 
investigated the role of p68 protein for keratinocyte proliferation and VEGF gene 
expression. First, we established HaCaT keratinocyte cell lines which stably 
overexpressed p68 protein (Figure 3.4d). As shown in Figure 3.19a (left panel), a 
constitutive and stable overexpression of p68 led to a strong increase in keratinocyte 
proliferation rates (+38 ± 6.1% within 24 h) as determined by incorporation of [
3H]-
thymidine into the cells. It is important to note that induction of endogenous p68 by 
serum (Figure 3.8c) in control cell lines attenuated the difference in cell proliferation 
(+20 ± 3.5%) between control and p68-overexpressing cell lines (Figure 3.19a, right  
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Figure 3.19 p68 functionally contributes to keratinocyte proliferation. a, stably transfected vector control (vector ctrl) 
and p68-overexpressing (p68-ORF) HaCaT cell lines were grown in the absence (left panel) or presence (right panel) of 
5% FCS as indicated. After 24 h, cell proliferation was determined by [
3H]-thymidine-incorporation into the cells. *, P < 
0.05 (Student's t test) as indicated by the brackets. Bars indicate the mean ±SD obtained from three (n=3) independent 
cell culture experiments. b , A quantification of [
3H]-thymidine-incorporation 24 h after transfection of the siRNA 
oligonucleotides (p68 siRNA) is shown for serum treated (left panel) and non-treated (right panel) cells. *, P < 0.05; n.s., 
not significant (Student's t test) as indicated by the bracket. Bars indicate the mean ±SD obtained from three (n=3) 
independent cell culture experiments. c, immunoblots showing the down-regulation of endogenous, FCS-induced p68 by 
p68-specific siRNA (left panel) and the subsequent down-regulation of PCNA. PCNA amounts were quantified by optical 
density (right panel). 
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panel). In line with these findings, a down-regulation of endogenous p68 by siRNA 
techniques in unprocessed HaCaT keratinocytes markedly reduced cellular 
proliferation rates. [
3H]-thymidine-based proliferation assays of non-stimulated and 
serum-induced HaCaT cells clearly demonstrated the pivotal role of p68 in 
keratinocyte proliferation. In serum-free conditions, when p68 is not induced in the 
cells, a transfection of p68-specific siRNA did not significantly alter the slow 
keratinocyte proliferation behavior (Figure 3.19b,  right panel). By contrast, 
transfection of p68-specific siRNA potently shut off serum-induced p68 protein 
synthesis in the cells (Figure 3.18). The observed and potent down-regulation of p68 
protein in serum-stimulated cells nearly completely abolished the mitogenic effect 
which was mediated by serum in the cells (Figure 3.19b,  left panel). In line, 
immunoblot analysis determined a marked reduction of proliferating cell nuclear 
antigen (PCNA) as a marker of cell proliferation in siRNA-treated keratinocytes 
(Figure 3.19c). 
As DEAD box proteins participate in the regulation of RNA/protein interactions 
(Tanner and Linder, 2001), we investigated the possibility that p68 is also functionally 
implicated in the control of gene expression in keratinocytes. VEGF has been shown 
to be expressed in wound margin keratinocytes, and its expression undergoes a 
complex regulation by growth factors, cytokines and NO in these cells (Brown et al., 
1992; Frank et al., 1995, 1999). For this reason we finally investigated the role p68 in 
serum- and NO-induced VEGF expression in HaCaT keratinocytes (Figure 3.20). 
Keratinocyte cell lines, which stably overexpressed p68 protein (p68-ORF #1 and 2), 
were treated with serum for 5 h. Serum is known to represent an inducer of VEGF 
expression in keratinocytes (Frank et al., 1995, 1999). Upon serum treatment, the 
p68 overexpressing cells were characterized by a marked increase in VEGF mRNA 
levels (Figure 3.20a). VEGF has been described as a NO-induced gene in 
keratinocytes (Frank et al., 1999), sharing this property with p68 (this study). Thus, it 
was tempting to speculate that NO-induced p68 might functionally participate in NO-
induced VEGF expression. To evidence this hypothesis, we induced treated HaCaT 
keratinocytes with GSNO in the presence or absence of p68-specific siRNA for 24 h 
and subsequently analyzed the cell culture supernatants by ELISA. As shown in 
Figure 3.20b, down-regulation of endogenous p68 by siRNA transfection significantly 
reduced the amount of NO-induced VEGF protein (1120 ± 133 pg/ml vs. 752 ± 47 Results 
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pg/ml; p < 0.05) compared to cells which received the scrambled siRNA 
oligonucleotides as a control. 
 
a 
b 
Figure 3.20 p68 functionally participates in keratinocyte VEGF expression.  a, quiescent stably transfected 
keratinocyte control (vector ctrl) and p68-overexpressing (p68-ORF) cell lines s were cultured in the absence (-FCS) or 
presence (+FCS) of 10% FCS for 5 h as indicated. Induction of VEGF mRNA expression in the cells was assessed by 
RNase protection assay (upper panel). 1000 counts of the hybridization probe was used as a size marker. A quantification 
of VEGF mRNA in control (vector ctrl) and p68-overexpessing (p68-ORF) cell lines is shown in the lower panel. **, P < 
0.01; n.s., not significant (Student's t test) as indicated by the brackets. Bars indicate the mean ±SD obtained from three 
(n=3) independent cell culture experiments. b, quantification of VEGF protein in cell culture supernatants from non-treated 
(-GSNO) and GSNO-treated (+GSNO) HaCaT keratinocytes after transfection of scrambled (scrambled) or p68-specific 
siRNA (p68 siRNA) oligonucleotides.*, P < 0.05; n.s., not significant (Student's t test) as indicated by the bracket. Bars 
indicate the mean ±SD obtained from three (n=3) independent cell culture experiments. 
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4 
Discussion 
___________________________________ 
 
4.1  Nitric oxide and skin 
 
Nitric oxide (NO) is now well established as an important messenger molecule in 
normal skin biology and also diseased skin (Bruch-Gerharz et al., 1998; Weller, 
1999). Studies on skin tissue have also demonstrated a key function of NO in the 
process of cutaneous wound healing (Frank et al., 2002). iNOS-deficient mice 
suffered from a delay in wound repair (Yamasaki et al., 1998). In line, an early 
induction of iNOS upon wounding has been well documented (Frank et al., 1998a), 
and inhibition of iNOS enzymatic activity during healing resulted in a markedly 
reduced reepithelialization (Stallmeyer et al., 1999). These findings strongly 
suggested NO to function as a potent mitogenic mediator for skin keratinocytes in 
vivo. Accordingly, it has been convincingly demonstrated that proliferation of cultured 
human keratinocytes could be mediated by low concentrations of NO (Krischel et al., 
1998; Frank et al., 2000a). However, it is particularly not much known about how NO 
exerts its unique actions on keratinocytes. To gain further insight into these 
mechanisms, we established and screened a subtractive keratinocyte cDNA library 
for NO-regulated genes to characterize new players in NO actions from the cells. 
 
 
4.2  Nitric oxide and p68 RNA helicase 
 
4.2.1  p68 is a novel NO-induced gene 
 
In this study the p68 DEAD box RNA helicase was identified as a novel NO-induced 
gene in keratinocytes. Besides not yet characterized transcripts which have been 
additionally isolated using this approach, we focused on p68, as previous work 
strongly suggested a role of this protein in dynamic cellular movements such as 
proliferation, transcription, translation, RNA splicing and stability, or ribosome 
assembly (Tanner and Linder, 2001). We hypothesized that p68 might at least 
partially contribute to or, moreover, mediate some of the well-established actions of Discussion 
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NO in keratinocyte biology. NO has been shown to control mRNA levels of a series of 
wound-related genes in keratinocytes such as VEGF or different chemokines (Frank 
et al., 1999, 2000c; Wetzler et al., 2000). Additionally, Cu/Zn superoxide dismutase 
(Cu/Zn SOD) has been identified to be exclusively induced by NO in keratinocytes. 
Furthermore, it was shown that the enzymatic actions of the Cu/Zn SOD are 
functionally connected to keratinocyte proliferation. Nevertheless, overexpression of 
the SOD enzyme did not alter gene expression in the cells (Frank et al., 2000a). 
Thus, NO actions on keratinocyte gene expression and proliferation appeared to be 
clearly dissected in molecular terms, as we had not yet identified a regulatory player 
in NO-controlled gene expression that also participated in the control of keratinocyte 
proliferation. Regarding published data, it was now reasonable to suggest that p68 
might serve a control of both keratinocyte gene expression as well as proliferation. 
 
4.2.2  How does nitric oxide exert its action on p68? 
 
We could convincingly demonstrate the potency of exogenous NO to induce p68 
expression in keratinocytes. Furthermore, we could demonstrate that NO acts by 
transcriptional activation of the p68 gene in keratinocytes and is independent from de 
novo protein synthesis.  However,  the situation for p68 actions appeared to be 
complex with respect to NO. Although lower amounts of NO (250 µM) were also 
capable to increase cellular p68 levels, a potent induction of p68 was only achieved 
with NO concentrations which have been shown to be cytostatic for cultured 
keratinocytes and characterized by a subsequent differentiation of the cells (Krischel 
et al., 1998). Furthermore, we could not detect an influence of endogenous NO on 
p68 expression. This is most probably due to the delayed appearance of iNOS in the 
cells after 12 h (Frank et al., 1998b, 2000a) and/or to the strong p68 induction by pro-
inflammatory cytokines which preceded the parallel NO-induced p68 expression. 
However, the in vivo situation during the process of wound healing differs from the in 
vitro situation. Despite proliferating keratinocytes of the wound margin, PMN and Mφ  
potently express iNOS and subsequently produce NO (Frank et al., 1998a). Thus, 
keratinocyte p68 expression in vivo most likely depends on the total amount of NO 
present at the wound site. Experiments which were performed in order to elucidate 
the signaling pathway by which NO exerts its action on p68 mRNA expression 
showed that neither the activation of the soluble guanylate cyclase nor the activation 
of MAPK cascades are involved in the modulation of p68 expression. This suggests Discussion 
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NO-induced p68 gene expression to be regulated by a direct modulation of 
transcription factors such as nitrosylation, nitration, and oxidation (Pfeilschifter et al., 
2001; Grisham et al., 1999). Until now, an ultimate “NO-responsive promoter 
element” has not been identified. NO is a molecule with both, anti-oxidant and pro-
oxidant properties, depending on the availability and concentration of potential 
reaction partners such as superoxide and hydrogen peroxide or other reactive 
oxygen species (ROS) (Pfeilschifter et al., 2001). It turned out that NO preferentially 
alters transcription factors that are sensitive to changes in the cellular redox status 
(Beck et al., 1999; Kröncke and Carlberg, 2000; Marshal et al., 2000; Pfeilschifter et 
al., 2001) such as NF-κ B, activator protein 1 (AP-1) and Sp-1. Notably, Rössler et al. 
(2000) could demonstrate that the p68 promoter contains a high affinity binding site 
for Sp1.  
 
 
4.3  p68 expression is triggered by wound-related 
keratinocyte mitogens and inflammatory stimuli 
 
The process of keratinocyte proliferation and differentiation represents one central 
process during tissue regeneration after cutaneous injury. Reepithelialization of the 
wounded area is driven by highly proliferative keratinocytes, which start to proliferate 
from the cut edges of the injured tissue, and subsequently migrate into the wound 
bed. This highly dynamic process finally leads to the formation of a massive bulk of 
proliferative keratinocytes, the hyperproliferative epithelium, which serves as a 
cellular source to drive the epithelial tongue to cover the wound area (Clark, 1996; 
Martin, 1997). Obviously, reepithelialization, essentially occurring in a close spatial 
and functional connection to the underlying granulation tissue, is central to wound 
closure. Therefore, formation of new epithelial structures has to be tightly controlled. 
Key players driving these processes are cytokines, growth factors, mitogens and NO 
(Moulin, 1995; Martin, 1997; Frank et al., 2002). We observed that pro-inflammatory 
cytokines were able to potently induce p68 gene and protein expression. Moreover, 
we could demonstrate that typical wound-related keratinocyte mitogens, such as 
EGF, TGF-α,  KGF, and serum appeared to potently trigger an increase in p68 in the 
cells in vitro. This observation was in line with a previous report that demonstrated 
the induction of p68 in serum-induced proliferating 3T3 fibroblasts (Stevenson et al., 
1998). Moreover, p68 has been associated to hyperproliferative states of epithelial Discussion 
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cells, as p68 was described to be overexpressed in nuclei from colorectal 
adenocarcinomas (Causevic et al., 2001). Accordingly, in our excisional wound 
healing model we found p68 protein to be exclusively expressed in epidermal 
keratinocytes. Interestingly, p68 mRNA was present in the epidermis and in the 
dermis of mouse skin. However, only keratinocytes and not fibroblasts were able to 
translate the p68 mRNA into protein. This is in contrast to the situation for 3T3 cells 
observed by Stevenson et al (1998) mentioned above. The discrepancy might be due 
to the different expression patterns already observed for p68 expression in vivo and 
in immortalized cell lines in vitro (Stevenson et al., 1998).  
 
 
4.4  p68 and proliferation 
 
p68 is developmentally and growth regulated and correlates with organ differentiation 
and maturation in the fetus (Stevenson et al., 1998). Another example arguing for 
p68 to be associated with cellular growth is a study by Iggo et al. (1991). The authors 
demonstrated that Dbp2p, the S. cerevisiae p68 homologue, plays a prominent role 
in the rRNA processing pathway. Interestingly, another publication convincingly 
showed that an accumulation of 35S pre-mRNA in a dbp2∆  yeast strain and the 
resulting growth defect could be reversed by human p68 (Bond et al., 2001).  
In terms of wound healing, the reepithelialization process is crucial to wound closure 
and characterized by keratinocyte proliferation and differentiation. We hypothesized 
that p68 might promote reepithelialization as our results clearly supported the direct 
contribution of p68 in the process of keratinocyte proliferation. We could show that 
p68 overexpression stimulated and p68 down-regulation attenuated the proliferative 
behavior of keratinocytes. It is important to note that p68 action on cell proliferation 
was restricted to mitogen-induced conditions. Thus, we could not find a marked 
attenuation of keratinocyte proliferation after down-regulation of endogenous p68 
under basal, non-stimulated conditions. Evidently, the augmentation of p68 
expression seems to represent a pivotal prerequisite to drive serum-induced 
proliferation in the cells. Therefore, it is reasonable to speculate that serum and, most 
likely, EGF and KGF as p68-inducing keratinocyte mitogens in vitro, might exert parts 
of their mitogenic potencies on wound keratinocytes by induction of p68. During the 
highly dynamic process of reepithelialization the proliferating and migrating wound 
keratinocytes induce the transcription of several genes such as VEGF, different Discussion 
 
71 
chemokines, integrins and different matrix metalloproteases (Clark, 1990; Saarialho 
et al., 1994; Salo et al., 1994; Clark et al., 1996; Pilcher et al., 1997; Frank et al., 
1999, 2000c; Wetzler et al., 2000). These changes in gene and protein expression 
require an active transcriptional and translational machinery. Accordingly, p68 is 
known to be involved in gene transcription, splicing and rRNA processing (Iggo et al., 
1991; Endoh et al., 1999; Watanabe et al., 2001; Bond et al., 2001; Liu, 2002; Fujita 
et al., 2003; Guil et al., 2003).  
 
 
4.5   Nuclear p68 localizes in nucleoli of keratinocytes 
 
An increasing number of nuclear proteins is described to interact with p68. Thus, it 
has been demonstrated that p68 is associated with the cAMP-dependent protein 
kinase-anchoring protein AKAP95 in the nuclear matrix of mammalian cells 
(Akileswaran  et al., 2001). Furthermore, p68 was found to co-localize with the 
nucleolar protein fibrillarin in nascent nucleoli during late telophase (Nicol et al., 
2000). These findings are consistent with our observation of an overall nuclear 
localization of p68 in keratinocytes, especially in nucleolar structures as assessed by 
our co-localization experiments using nucleolin as a prototypical nucleolar marker 
protein. Interestingly, p68 has an additional RNA-binding site in its C-terminus (aa 
477-504) (Hirling et al., 1989) which is commonly found in RNA-binding proteins 
(Mattaj et al., 1993; Burd et al., 1994), such as nucleolin (Ghisolfi et al., 1992) or 
heterogeneous nuclear ribonucleoprotein particle (hnRNP) A1 (Liu and Dreyfuss, 
1995). In the 1960s, it was demonstrated that nucleoli are the site of ribosome 
biogenesis (Scherl et al., 2002). However, the molecular mechanisms governing the 
assembly of ribosome biogenesis are still poorly defined. Recently, Scherl et al. 
(2002) confirmed the proposed plurifunctional nature of the nucleolus (Bond and 
Wold, 1993; Pederson, 1998; Buonomo et al., 1999; Olson et al., 2000) by a 
functional proteomic analysis of the human nucleolus. The authors showed that, in 
addition to the expected ribosomal proteins and proteins involved in ribosome 
biogenesis, regulators and components of the translation machinery (ribosomes, 
tRNAs, signal recognition particle, mRNAs), chaperones and proteins involved in 
mRNA processing are also present within the nucleoli. Accordingly, Scherl et al. 
(2002) speculate about transcription and translation being coupled in nucleoli. Discussion 
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Notably, p68 is a member of the DEAD-box family which is discussed to be involved 
in transcriptional and also in translational events (Tanner and Linder, 2001). 
 
 
4.6  Is p68 a transcriptional co-activator of VEGF gene 
expression? 
 
Evidently, p68 RNA helicase might function also as a transcriptional co-activator. 
Endoh et al. (1999) showed that p68 acts as a specific co-activator of the human 
estrogen receptor α  AF-1 (hERα AF-1), thus pointing out a role for p68 in hormonal-
driven transcription.  Moreover, p68 has been shown to directly interact with the 
transcriptional coactivators p300 and CREB-binding protein (CBP) to promote gene 
transcription in complex with RNA polymerase II (Rossow and Janknecht, 2003). 
p300 and CBP are essential during embryogenesis and can modulate gene 
expression programs involved in cell growth, differentiation, homeostasis and viral 
pathogenesis (Goodman and Smolik, 2000; Janknecht et al., 2002). Noteably, p68 
has been found to associate with nuclear cAMP-dependent protein kinase-anchoring 
protein 95 (AKAP95) (Akileswaran et al., 2001) which contains a DNA and a protein 
kinase A (PKA) binding domain and is thought to link the nuclear matrix to specific 
cell-signaling events (Coghlan et al., 1994). Since p68 also interacts with p300, the 
interaction between p68 and AKAP95 may serve as a mechanism to drive cAMP 
regulated gene expression. Interestingly, CBP/p300 proteins have been 
demonstrated to essentially contribute in hypoxia-induced transcriptional activation of 
the VEGF gene in vitro and in a model of tumor growth in vivo (Kung et al., 2000). In 
this study we could show that p68 expression is functionally connected to 
keratinocyte VEGF gene expression. Furthermore, we could demonstrate that NO-
induced p68 is able to alter NO-induced VEGF protein expression, as down-
regulation of endogenous p68 by siRNA transfection experiments significantly 
reduced the amount of NO-increased VEGF protein. p68 overexpression alone was 
not able to induce VEGF gene expression. Thus, it is reasonable to speculate that 
p68 acts as transcriptional co-activator. However, we could not rule out that p68 
might also control VEGF expression at different post-transcriptional levels, as RNA 
helicases are known to essentially participate in the formation and function of the 
spliceosome (Will and Lührmann, 1997; Staley and Guthrie, 1998), in ribosome 
biogenesis (Tanner and Linder, 2001) and the initiation of translation (Pause and 
Sonenberg, 1993; Svitkin et al., 2001).   Discussion 
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4.7  p68 and wound healing 
 
Wound healing is a well-ordered and highly coordinated process involving 
inflammation, cell proliferation, matrix deposition, and tissue remodeling. After injury, 
new tissue formation comprises reepithelialization and granulation tissue formation. 
The latter process encompasses macrophage accumulation, fibroblast ingrowth, 
matrix formation, and angiogenesis (Clark, 1996). Inflammation, reepithelialization, 
and granulation tissue formation are driven in part by a complex mixture of growth 
factors and cytokines, which are released coordinately into the area of injury. We 
have observed p68 to be induced by NO, wound-related keratinocyte mitogens, and 
pro-inflammatory cytokines and, moreover, we could demonstrate that p68 promotes 
keratinocyte proliferation and VEGF gene expression in vitro. Thus, it was interesting 
to investigate p68 mRNA and protein expression during wound healing. Our wound 
healing studies supported the suggestion that keratinocyte mitogens might overcome 
the potency of NO to control p68 expression. We found a constitutive expression of 
p68 in non-wounded skin, which was restricted to the nucleoli of epidermal 
keratinocytes. In line, a previous study indicated the ubiquitous expression of p68 in 
newborn and adult mice and rats, respectively. However, although skin tissue was 
not included, this study suggested that the presence of p68 did not necessarily reflect 
the extent of cell proliferation in the adult (Stevenson et al., 1998). It was completely 
unexpected for us to recognize elevated levels of p68 mRNA and protein in iNOS-
deficient animals compared to wild-type mice. We found lowest amounts of p68 in the 
inflammatory phase of wounding, which is characterized by a dramatic increase in 
proliferation of keratinocytes located at the margins of the wound. However, it is 
important to note that p68 had not diminished, but could be clearly localized in 
keratinocyte nuclei of the developing neo-epithelium. Moreover, p68 mRNA was 
present at the wound margins (hyperproliferative epithelia) and in the inner region of 
the wound (granulation tissue) whereas p68 protein was predominantly expressed at 
the wound margins. These results clearly suggest keratinocytes as predominant 
producers of p68 protein. Interestingly, only a defined number (about 20% to 30%) of 
wound keratinocytes expressed p68. Thus, it is tempting to speculate that the 
presence of p68 in keratinocyte nuclei might be associated to a distinct phase of the 
cell cycle. Consistently, p68 has been described to localize in the nuclei of interphase 
cells in vitro (Lamm et al., 1996; Nicol et al., 2000), an observation that supports the 
presence of high numbers of p68 negative cells in normal wound tissue, as the neo-Discussion 
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epithelium is largely characterized by mitogenic cells (Stallmeyer et al., 1999). 
Evidently, the localization of p68 in interphase cells might provide the explanation for 
elevated p68 levels observed in NO-deficient healing. iNOS-deficient mice were 
characterized by a marked delay in wound closure (Yamasaki et al., 1998) and 
inhibition of iNOS during repair resulted in a nearly complete loss of wound 
keratinocyte proliferation (Stallmeyer et al., 1999). Thus, the increased levels of p68 
in the absence of the keratinocyte mitogen NO strongly argues for high numbers of 
interphase cells and might reflect the non-proliferative status of keratinocytes in NO-
deficient wounds. However, this argumentation must remain unsolved with respect to 
cell culture conditions, as, by contrast, we had to recognize that serum-induced 
keratinocyte proliferation was dependent on the co-induction of p68 in vitro. Thus, the 
early re-increase and over-representation of p68 in impaired repair in NO-deficient 
animals might be interpreted as an adaptive mechanism to overcome the disturbed 
responsiveness of keratinocytes to mitotic stimuli in conditions of delayed healing. 
 
 
4.8   Clinical relevance 
 
The biological functions of RNA helicases are diverse and include gene transcription, 
RNA processing, mRNA translation, ribosome assembly, cell differentiation, cell 
development and division (Tanner and Linder, 2001). Therefore, these proteins are 
considered to be promising candidates for anticancer drugs (Tanner and Linder, 
2001). Indeed, there are examples of DEAD box proteins which are implicated not 
only in growth and division but also in tumor development. For example, the DEAD-
box family member Rck/p54 has been shown to be overexpressed in neuroblastoma, 
glioblastoma, rhabdomyosarcoma and lung cancer cells as well as in colorectal 
tumors (Akao et el., 1995; Nakagawa et al., 1999). Furthermore, the DDX1 RNA 
helicase gene is often co-amplified with N-myc in retino- and neuroblastomas 
(Godbout and Squire, 1993; Squire et al., 1995; George et al., 1996). p68 itself has a 
binding site for Myc, is overexpressed in colorectal tumors when compared to normal 
tissue samples (Causevic et al., 2001), and involved in splicing regulation of c-H-ras 
proto-oncogene (Guil et al., 2003). Moreover, mutated p68 was identified to be the 
immunodominant antigen responsible for tumor rejection in mice (Dubey et al., 1997). 
The authors showed that the antigen, which was generated by a somatic point 
mutation in the p68 gene, was recognized by CD8
+ T cells and thus led to the Discussion 
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rejection of the previous transplanted tumor cell line. In line with these data, our 
observations demonstrated, that p68 promoted proliferation and most likely functions 
as transcriptional co-activator in VEGF gene transcription. VEGF is known to be an 
angiogenic growth factor and a potent stimulant for vascularization of solid tumors 
(Brekken et al., 1998). Thus, p68 might promote tumor growth by enhancing VEGF 
transcription. It is known that CBP/p300 proteins contribute in hypoxia-induced 
transcriptional activation of the VEGF gene in vitro and in a model of tumor growth in 
vivo (Kung et al., 2000). As p68 has been found to interact with the multiprotein 
complex containing Pol II and CBP/p300 (Rossow and Janknecht, 2003), one might 
speculate that p68 promotes VEGF gene transcription as part of the CBP/p300/Pol II 
complex. The modulation of VEGF gene expression is also of interest in terms of 
wound healing. VEGF has been shown to stimulate wound angiogenesis and its 
reduced expression or its accelerated degradation were found to be associated with 
wound healing defects (Frank et al., 1995; Swift et al., 1999; Lauer et al., 2000; 
Kämpfer et al., 2001).  
In addition, it seems reasonable to speculate that p68 is implicated in the 
inflammatory skin disease psoriasis. Histological examination of psoriatic plaques 
reveals three major pathogenic factors: abnormal keratinocyte differentiation, 
hyperproliferation of keratinocytes and infiltration of inflammatory cells into the skin 
(Ortonne, 1996). Moreover, several studies demonstrated the involvement of different 
inflammatory cytokines, chemokines and their receptors in psoriasis (Castells-
Rodellas et al., 1992; Kapp, 1993; Schlaak et al., 1994; Michel et al., 1997; Debets et 
al., 1997; Kulke et al., 1998;). As we found p68 to be potently induced by pro-
inflammatory cytokines and to participate in proliferation, this helicase is a likely 
candidate to be implicated in psoriasis.  Summary 
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___________________________________ 
 
p68
pro-inflammatory
cytokines
wound-related 
mitogens
NO
keratinocyte VEGF expression
in keratinocytes
keratinocyte
proliferation
reepithelialization
angiogenesis
?
?
?
in vitro in vivo
 
  Figure 4.1 Schematic view of the hypothesized functional roles of p68 in keratinocyte biology and during 
 wound  healing 
 
 
Nitric oxide (NO) represents a short-lived mediator that pivotally drives keratinocyte 
movements during cutaneous wound healing. In this study, we have identified p68 
DEAD box RNA helicase (p68) from a NO-induced differential keratinocyte cDNA 
library. Subsequently, we have analyzed regulation of p68 by wound-associated 
mediators in the human keratinocyte cell line HaCaT. NO, serum, growth factors and 
pro-inflammatory cytokines were potent inducers of p68 expression in the cells. p68 
was constitutively expressed in murine skin, but rapidly down-regulated upon injury. 
The down-regulation appeared to be transient, as p68 protein expression increased 
again after the inflammatory phase of repair. However, p68 protein expression did 
not completely disappear during wound inflammation, as immunohistochemistry and 
cell fractionation analysis revealed a restricted localization of p68 in keratinocyte 
nuclei of the developing epithelium. In line, cultured human (HaCaT) and murine Summary 
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(PAM 212) keratinocyte cell lines showed a nuclear localization of the helicase. 
Moreover, confocal microscopy revealed a strong localization of p68 protein within 
the nucleoli of the keratinocytes. Functional analyses demonstrated that p68 strongly 
participates in keratinocyte proliferation and gene expression. Keratinocytes that 
constitutively overexpressed p68 protein were characterized by a marked increase in 
serum-induced proliferation and vascular endothelial growth factor (VEGF) 
expression, whereas down-regulation of endogenous p68 using small interfering 
RNA (siRNA) markedly attenuated serum-induced proliferation and VEGF 
expression. Altogether, our results suggest a tightly controlled expression and 
nucleolar localization of p68 in keratinocytes in vitro and during skin repair in vivo that 
functionally contributes to keratinocyte proliferation and gene expression. 
 References 
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7 
Appendix 
___________________________________ 
 
7.1 Abbreviations 
 
aa  amino acid  
AKAP95  cAMP-dependent protein kinase-anchoring protein 95 
Ang angiopoietin 
AP-1  activator protein 1 
ATP adenosine  triphosphate 
bFGF  basic fibroblast growth factor 
BSA  bovine serum albumin 
CBP  CREB binding protein 
cDNA  copy of complementary DNA 
cGMP  cyclic guanosine monophosphate 
CHX cycloheximide 
CO carbon  monoxide 
cpm  counts per minute 
CREB  cAMP response element binding protein 
ctrl control 
cyt cytokine 
d day 
DEPC diethyl  pyrocarbonate 
dest distilled 
DETA-NO (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate 
DG diacylglycerol 
DMEM  Dulbecco`s Modified Eagles Media 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic  acid 
DNase deoxyribonuclease 
DTT dithiothreitol 
E. coli  Escherichia coli Appendix 
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ECL enhanced  chemiluminescence 
EDTA ethylenediaminetetraacetic  acid 
EGF  epidermal growth factor 
eIF-4a  eucaryotic initiation factor-4A 
ELISA  enzyme-linked immunosorbent assay 
eNOS  endothelial nitric oxide synthase 
ERK  extracellular signal regulated kinase 
et al.  et alter 
FCS  fetal calf serum 
fig figure 
g gravitation  (9.81m/s
2) 
GAPDH  glyceraldehyde 3-phosphate dehydrogenase 
GFP  green fluorescent protein 
GSNO S-nitroso-glutathione 
h hour(s) 
HEK  human embryonal kidney cells 
HEPES N-(2-hydroxyethyl)piperazine-N`-(2-ethanesulfonic  acid) 
hERα AF-1  human estrogen receptor α  AF-1 
hnRNP  heterogeneous nuclear ribonucleoprotein particle 
IFN interferon 
IGF  insulin-like growth factor 
IL interleukin 
iNOS  inducible nitric oxide synthase 
IPTG isopropylthiogalactoside 
Iκ B inhibitor  of  κ B 
JNK c-Jun-N-terminal  kinase 
kDa kilo  Dalton 
KGF  keratinocyte growth factor 
LB Lauria-Bertani 
L-NIL L-N
6-(1-iminoethyl)lysine 
L-NMMA N
G-monomethyl-L-arginine 
LPS lipopolysaccharide 
MAPK  mitogen activated protein kinase 
MCP  monocyte chemoattractant protein 
min minute(s) Appendix 
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MIP  macrophage inflammatory protein 
MMP matrix  metalloproteinase 
mRNA messenger  RNA 
NF nuclear  factor 
nNOS  neuronal nitric oxide synthase 
NO nitric  oxide 
NS 2028  [4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)benz(b)(1,4)oxazin-1-one] 
nt nucleotides 
OD optical  density 
ODQ  [1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one] 
p68  p68 DEAD box RNA helicase 
PAGE  polyacrylamid gel elektrophoresis 
PBS  phosphate buffer saline 
PDGF  platelet-derived growth factor 
pH potentia  hydrogenii 
PIPES piperazine-N,N`-bis(2-ethanesulfonic  acid) 
PKA  protein kinase A  
PKC  protein kinase C 
poly-(A) polyadenyclic  acid 
PVDF polyvinylidene  fluoride 
RNA ribonucleic  acid 
RNase ribonuclease 
ROS  reactive oxygen species 
rpm  rounds per minute 
RPMI  Roswell Park Memorial Institute 
RT reverse  transcription 
SAP  stress activated protein kinase 
SDS  sodium dodecyl sulfate 
sGC  soluble guanylyl cyclase 
siRNA  small interfering RNA 
SNP sodium  nitroprusside 
SpNO spermine-NONOate 
SV40  simian virus 40 
TCA trichloroacetic  acid 
TEMED N,N,N`,N`-tetramethylethylenediamine Appendix 
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TGF  transforming growth factor 
Th  T helper cell 
TNF  tumor necrosis factor 
TNFα   tumor necrosis factor α   
TPA 12-O-tetradecanoylphorbol-13-acetate 
Tris tris(hydroxymethyl)aminomethane 
tRNA transfer  RNA 
U unit(s) 
UTP uridine  5`-triphosphate 
v/v  volume per volume 
VEGF  vascular endothelial growth factor 
w/v  weight per volume 
wt wild  type 
X-gal 5-bromo-4-chloro-3-indolyl-ß-D-galactoside 
YC-1 [3-(5`-Hydroxymethyl-2`-furyl)-1-benzylindazole] 
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7.4 Deutsche  Zusammenfassung 
 
7.4.1  Haut und Wundheilung 
 
Die Haut grenzt als größtes Organ den Körper von seiner Umwelt ab. Sie schützt den 
Organismus vor schädigenden Einwirkungen sowie vor eindringenden 
Mikroorganismen. Neben diesen protektiven Aufgaben vermittelt die Haut als 
Sinnesorgan durch zahlreiche Sensoren Berührungs-, Druck-, Temperatur- und 
Schmerzreize. Zusätzlich ist sie an der Regulation der Körpertemperatur und des 
Wasserhaushaltes beteiligt (Thews et al., 1999; Freinkel und Woodley, 2001). Eine 
Verletzung der Haut zieht daher schwerwiegende Folgen nach sich, weshalb eine 
schnelle funktionelle Wiederherstellung dieses Organs unabdingbar ist. Der Prozess 
der Wundheilung gliedert sich in verschiedene Phasen, die sowohl zeitlich als auch 
räumlich überlappen (Moulin, 1995, Singer und Clark, 1999).  
Bei einer Verletzung werden Blutgefäße beschädigt. Es kommt zu Blutung, 
Aggregation und Degranulation von Blutplättchen, Koagulation des Blutes und 
schlussendlich zur Bildung des Wundschorfes. Aktivierte, degranulierende 
Blutplättchen setzen hierbei eine Reihe wichtiger chemotaktischer Moleküle und 
Wachstumsfaktoren frei. Der Wundschorf, der sich hauptsächlich aus einem Netz 
von Fibrinfibrillen, Fibronektin, Vitronektin und Thrombospondin zusammensetzt, 
dient als provisorische Matrix, durch die und über die Zellen während des 
Heilungsprozesses wandern können (Clark, 1996; Martin, 1997). 
Der Beginn der Entzündungsphase ist gekennzeichnet durch einen massiven 
Einstrom neutrophiler Phagozyten (PMN), welche bereits wenige Minuten nach 
Verletzung in das verwundete Gewebe einwandern (Martin, 1997). Neutrophile 
werden hierbei hauptsächlich von chemotaktischen Zytokinen der CXC-Familie an 
den Wundort rekrutiert (Luster, 1998; Baggiolini, 1998). Einströmende Neutrophile 
haben die Aufgabe, eingedrungene Mikroorganismen zu phagozytieren und dienen 
als Quelle wichtiger Zytokine wie IL-1ß und TNF-α  (Hübner et al., 1996). Etwa 24h 
nach Verletzung lösen Makrophagen (Mφ)  die PMN als vorherrschende Immunzellen 
ab. Verantwortlich für die Einwanderung der Mφ  sind überwiegend chemotaktische 
Zytokine der CC-Familie (DiPietro et al., 1995, 1998). Mφ  schütten eine Vielzahl von 
Zytokinen und Wachstumsfaktoren aus und spielen so eine wichtige Rolle im 
Wundheilungsprozess (DiPietro et al., 1995, Moulin, 1995). Appendix 
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Die Reepithelialisierung setzt wenige Stunden nach Verletzung ein. Charakteristisch 
für diese Phase des Wundheilungsprozesses sind eine gesteigerte 
Keratinozytenproliferation sowie die Migration der Keratinozyten über das Wundbett. 
Hierbei bilden Keratinozyten an den Wundrändern große hyperproliferierende 
Epithelien aus, welche fortwährend neu gebildete Zellen ins Wundinnere abgeben 
und so zu einem epithelialen Wundschluss beitragen. Verantwortlich für den Anstieg 
der Zellteilung sind hauptsächlich die Keratinozyten-Mitogene EGF, TGF-α , KGF und 
Stickstoffmonoxid (Stallmeyer et al., 1999; Werner und Grose, 2003). Die Migration 
erfolgt mittels Substratadhäsion, wobei Integrine an Komponenten der extrazellulären 
Wundmatrix (Fibronektin, Vitronektin, Kollagen) binden (Clark, 1990; Clark et al., 
1996), sowie durch die Sekretion verschiedener Proteasen, u.a. Matrix- 
Metalloproteasen, die die Matrixproteine des Wundschorfes verdauen (Salo et al., 
1994; Pilcher et al., 1997; Saarialho et al., 1994).  
Die Bildung von Granulationsgewebe beginnt etwa vier Tage nach Verletzung. Der 
Aufbau der Matrix wird hauptsächlich durch das Zusammenspiel von Fibroblasten, 
Mφ  und Endothelzellen verrichtet und steht unter besonderer regulatorischer 
Kontrolle von TGF-ß1 (Clark et al., 1995). Eine ausreichende Versorgung des neu 
gebildeten Gewebes mit Sauerstoff und Nährstoffen wird durch die 
Blutgefäßneubildung (Angiogenese) erzielt. Die daran beteiligten mikrovaskulären 
Zellen (Madri et al., 1991, 1992a,b) werden durch eine große Zahl von Faktoren zur 
Migration und Proliferation angeregt. VEGF repräsentiert hier einen der wichtigsten 
Faktoren (Keck et al., 1989), der nach Verletzung vor allem von Keratinozyten des 
hyperproliferativen Epithels sekretiert wird (Brown et al., 1992; Frank et al., 1995). 
Die Remodellierungsphase repräsentiert das Ende der Gewebsregeneration und ist 
gekennzeichnet durch einen kontrollierten Kollagenumbau, der von Matrix 
Metalloproteasen gesteuert wird (Mignatti, 1996). Eine perfekte Rekonstruktion des 
beschädigten adulten Gewebes ist selbst unter optimalen Bedingungen nicht zu 
erreichen. 
 
 
7.4.2  Sickstoffmonoxid und Wundheilung 
 
Wie man heute weiß, ist das Gas Stickstoffmonoxid (NO) in eine Vielzahl 
verschiedener physiologischer und pathophysiologischer Prozesse involviert (Beck et 
al., 1999; Moncada et al., 1991). NO wird von drei verschiedenen Isoenzymen, den Appendix 
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NO-Synthasen (NOS) gebildet, welche die Umwandlung der Aminosäure L-Arginin in 
die Produkte Zitrullin und NO katalysieren (Nathan und Xie, 1994). Die endotheliale 
NOS (eNOS) sowie die neuronale NOS (nNOS) werden Ca
2+/Calmodulin-abhängig 
reguliert, während die induzierbare NOS (iNOS) in ein einer Vielzahl verschiedener 
Zelltypen erst nach Stimulation mit pro-entzündlichen Zytokine und Endotoxin 
exprimiert wird (Moncada et al., 1991; Nathan und Xie, 1994). 
Alle drei NO-Synthasen werden in der Haut exprimiert. Das entstehende NO ist hier 
an der Regulation der Vasodilatation, der Melanogenese und der Abwehr von 
pathogenen Mikroorganismen beteiligt (Bruch.Gerharz et al., 1998). Darüber hinaus 
spielt dieses Gas eine wichtige Rolle während der kutanen Wundheilung. Eine 
verzögerte Gewebsregeneration ist charakteristisch für iNOS-defiziente Mäuse. 
Dieser Wundheilungsdefekt konnte jedoch durch die Applikation eines adenoviralen 
iNOS-cDNA-Konstruktes nahezu vollständig aufgehoben werden (Yamasaki et al., 
1998). Grundsätzlich kommt es nach Verletzung zu einer Induktion der iNOS. Die 
iNOS wird dabei überwiegend von PMN, Mφ  und Keratinozyten des 
hyperproliferierenden Gewebes exprimiert (Frank et al., 1998a; Reichner et al., 
1999). Weiterhin ist bekannt, dass die Hemmung der iNOS durch den selektiven 
iNOS-Hemmstoff L-NIL zu einer verminderten Zellteilung in den Keratinozyten des 
Wundrandes führt (Stallmeyer et al., 1999). Neben dieser Funktion als Keratinozyten-
Mitogen reguliert NO die Expression verschiedener wundassoziierter Gene (VEGF, 
Cu/Zn SOD, Chemokine) in Keratinozyten (Frank et al., 1999, 2000a, c; Wetzler et 
al., 2000). 
 
 
7.5.3  p68 RNA Helikase und Wundheilung 
 
Die p68 RNA Helikase ist ein Mitglied der DEAD-Box Familie RNA abhängiger 
Helikasen. Identifiziert wurde p68 im Jahre 1980 eher zufällig, da es mit dem 
Antikörper gegen das große T-Antigen das Affenvirus 40 (SV 40) kreuzreagierte 
(Lane und Hoeffler, 1980). Das Sequenzierungsergebnis der entsprechenden p68 
komplementären DNA (cDNA) klassifizierte dieses Molekül als Homolog des 
eukaryontischen Translations-Initiationsfaktor eIF-4A (Ford et al., 1988). Beiden 
Proteinen war eine hoch konservierte Domäne gemein, die DEAD (Asp-Glu-Ala-
Asp)-Domäne, die im Folgenden der Familie ihren Namen gab (Linder et al., 1989). 
DEAD Proteine katalysieren mittels Nucleosid-Triphosphat (NTP) Hydrolyse das Appendix 
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Aufwinden doppelsträngiger RNA Moleküle (Tanner and Linder, 2001). Diese hoch-
konservierten Proteine sind damit an Prozessen des RNA-Metabolismus beteiligt. 
Hierzu zählen Transkription, prä-mRNA Splicing, RNA-Export, Translation und RNA-
Degradation (de la Cruz et al., 1999; Kadare and Haenni, 1997). Die 
Aminosäuresequenz der p68 Helikase ist ebenfalls stark konserviert So sind das 
humane und murine Protein zu 98% identisch (Lemaire and Heinlein, 1993) und 
selbst das Homolog der Hefe Saccharomyces cerevisiae, Dbp2, stimmt zu 55% mit 
dem humanen p68 überein (Iggo et al., 1991). Auch die Funktion der p68 Helikase 
hat sich im Laufe der Evolution kaum verändert. Einen Beweis hierfür liefert die 
Arbeit von Bond et al. (2001), in welcher die Autoren den Wachstumsdefekt dbp2-
defizienten Hefezellen durch die Transformation des humanen Homologs aufheben 
können.  
Die Expression der p68 ist assoziiert mit der Zellteilung und korreliert mit der Reifung 
und Differenzierung fötaler Organe (Stevenson et al., 1998). Dieser Zusammenhang 
zwischen Proliferationsstatus der Zelle und p68-Induktion besteht jedoch nicht 
immer. So beobachteten Stevenson et al. (1998), dass Organe mit hoher 
Zellteilungsrate nicht zwangsläufig einen hohen p68-Spiegel aufweisen, während 
eine p68 Überexpression im Tumorgewebe bei Mast- und Dickdarmkrebs gefunden 
wurde (Causevic et al., 2001). Weiterhin ist die p68 Helikase ein essentieller Spleiß-
Faktor (Liu, 2002), sowie ein Transkriptions-Kofaktor (Endoh et al., 1999; Watanabe 
et al., 2001:, Rossow und Janknecht, 2003). 
Zusammenfassend lässt sich demnach sagen, dass es sich bei p68 um ein Protein 
handelt, welches an verschiedenen Prozessen des Zellmetabolismus beteiligt ist und 
dessen Expression mit der Zellteilung assoziiert ist. Diese Eigenschaften deuten auf 
eine Rolle der p68 während der kutanen Wundheilung hin, welche einen 
dynamischen Prozess darstellt, der durch Proliferation und Migration verschiedener 
Zelltypen gekennzeichnet ist (Clark, 1996; Martin, 1997). 
 
 
7.5.4 NO und weitere Keratinozyten-Mitogene induzieren die 
Expression der p68 RNA Helikase in vitro 
 
In dieser Arbeit wurde die p68 RNA Helikase als neues NO-reguliertes Gen in 
Keratinozyten identifiziert. Die Stimulation von HaCaT Keratinozyten mit 
verschiedenen NO-Donatoren (GSNO, Sp-NO) führte jeweils zu einer gesteigerten 
p68-Expression sowohl auf mRNA als auch auf Proteinebene. Darüber hinaus Appendix 
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konnte gezeigt werden, dass typische wundassoziierte Keratinozytenmitogene wie 
TGF-α , EGF und KGF die Expression der p68 in Keratinozyten induzieren. Ein pro-
entzündliches Zytokingemisch (TNFα , IFNγ , Il-1ß) bewirkte ebenfalls eine 
Expressionssteigerung.  
 
 
7.5.5  p68 lokalisiert in Keratinozyten Nucleoli 
 
In der Literatur finden sich Beispiele, die eine Interaktion von p68 mit Kernproteinen 
belegen. Akileswaran et al. (2001) konnten zeigen, dass p68 an das cAMP-
abhängige Proteinkinase Anker Protein AKAP95 assoziiert. Eine Kolokalisation mit 
Fibrillarin in Nucleoli während der späten Telophase wurde ebenfalls anschaulich 
dokumentiert (Nicol et al., 2000). Diese Beobachtungen sind in Übereinstimmung mit 
unseren Ergebnisse: p68 ist sowohl in vitro (HaCaT und PAM Keratinozyten) als 
auch in vivo (Wunden) im Kern von Keratinozyten lokalisiert. Mit Hilfe eines p68-GFP 
Fusionsproteins konnten wir die p68 Lokalisation näher charakterisieren. Neben der 
erwarteten Kernlokalisation, zeigte p68 eine Akkumulation in den Keratinozyten-
Nuleoli. Als spezifisches Nucleoli-Marker Protein wurde Nucleolin verwendet (Bugler 
et al., 1982; Shaw and Jordan, 1995). Nucleoli sind Organellen, in denen ribosomale 
RNA transkribiert und die Ribosomen-Untereinheiten zusammengesetzt werden. In 
jüngster Zeit werden sie als Zellbestandteile mit plurifunktionellem Charakter 
diskutiert, in denen sowohl transkriptionelle als auch translationelle Vorgänge 
vonstatten gehen (Scherl et al., 2002). 
 
 
7.5.6  p68 beeinflußt die Zellteilung in Keratinozyten  
 
Die Reepithelialisierungsphase während des Prozesses der Wundheilung ist unter 
anderem gekennzeichnet durch einen Anstieg der Zellteilungsrate von Keratinozyten. 
Da die p68 Expression mit der Zellteilung assoziiert ist (Stevenson et al., 1998), liegt 
ein Zusammenhang zwischen dem zellulären p68-Spiegel und dem 
Proliferationsstatus in Keratinozyten nahe. Zur Klärung dieser Hypothese wurden 
p68-überexprimierende Zelllinien untersucht. Parallel wurde die p68 Protein 
Expression mittels spezifischer siRNA Moleküle gehemmt. Es zeigte sich, dass eine 
p68 Überexpression einen Anstieg der Keratinozytenproliferation zur Folge hatte, 
während die Hemmung des p68 Proteins die Zellteilungsrate sinken ließ. Folglich ist Appendix 
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p68 ein Regulator der Proliferation von Keratinozyten in vitro und damit auch ein 
potentieller Modulator der Keratinozytenproliferation während der 
Reepithelialisierung. 
 
 
7.5.7  p68 ist beteiligt an der Regulation der VEGF-Expression 
 
Eine effiziente Angiogenese stellt die Nähr- und Sauerstoffversorgung im 
regenerierenden Gewebe sicher. VEGF gilt hierbei als ein wichtiger angiogenetischer 
Faktor (Keck et al., 1989), der vor allem von Keratinozyten des Wundrandes gebildet 
wird. Die VEGF-Expression unterliegt einer komplexen Regulation verschiedener 
Wachstumsfaktoren, Zytokine und NO (Brown et al., 1992; Frank et al., 1995, 1999). 
Die Transkriptionskofaktoren CBP und p300 sind zusammen mit der RNA- 
Polymerase II maßgeblich an der Hypoxie-induzierten VEGF-Expression beteiligt 
(Kung  et al., 2000). Endoh et al. (1999) konnten demonstrieren, dass p68 
gemeinsam mit CBP/p300/RNA-Pol II an der Genexpression beteiligt ist. Wir 
vermuteten daher einen Zusammenhang zwischen p68-Induktion und VEGF-
Expression. p68-überexprimierende Keratinozyten-Zelllinien zeigten unter mitogenen 
Bedingungen einen Anstieg der VEGF-Produktion, während die Hemmung des p68 
Proteins mit Hilfe spezifischer siRNA Moleküle die VEGF-Expression in NO-
induzierten HaCaT Keratinozyten senkte. Daraus ergibt sich, dass p68 an der 
Mitogen-induzierten VEGF-Expression funktionell beteiligt ist. Eine Funktion als 
Transkriptionskofaktor zusammen mit CBP/p300/RNA-Pol II erscheint daher möglich. 
 
 
7.5.8  p68 Expression während der kutanen Wundheilung in vivo 
 
Mit Hilfe eines exzisionalen Wundheilungsmodells der Maus wurde die Expression 
der p68 RNA Helikase während der Wundheilung untersucht. Es zeigte sich, dass in 
unverletzter Haut p68 konstitutiv exprimiert wird. Nach Verletzung und während des 
gesamten Wundheilungsverlaufs bleibt der p68 mRNA-Spiegel nahezu konstant, 
während die p68-Proteinspiegel erst drei Tage nach Verwundung wieder detektierbar 
sind. Eine Trennung von Epidermis und Dermis zeigte, dass beide Gewebe in der 
Lage sind p68 mRNA zu transkribieren. Das entsprechende p68 Protein wird 
allerdings nur von Keratinozyten der Epidermis und nicht von mesenchymalen Zellen 
der Dermis translatiert. Bestätigend zeigten immunohistochemische Appendix 
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Untersuchungen, dass sich die p68 Expression auf epidermale Keratinozyten 
beschränkt.  
Überraschend ist in iNOS-defizienten Mäusen der p68-Spiegel vergleichsweise 
höher. Dieser unerwartete Umstand ist vielleicht durch einen kompensatorischen 
Anpassungsmechanismus in iNOS-defizienten Tiere zurückzuführen, die eine 
verminderte Keratinozytenproliferation aufweisen (Yamasaki et al., 1998; Stallmeyer 
et al., 1999). 
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